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Summary 
Bronchial hyperresponsiveness, diagnosed asthma, respiratory symptoms 
suggestive of asthma and atopy were studied in first year students of 
Chinese ethnic origin, attending the Chinese University of Hong Kong. 
Relationships between bronchial hyperresponsiveness, asthma, respiratory 
symptoms and atopy were investigated. Additionally associations with 
environmental and geographical factors and parental history were studied. 
All students entering the first year of study at the University in September 
1989 were sent a questionnaire to determine lifetime prevalence of 
respiratory and atopic symptoms, thereafter students reporting symptoms 
suggestive of asthma completed a second questionnaire to determine 
symptoms within the past year. Questionnaire data were obtained from 
1,610 and 724 students respectively. Bronchial responsiveness to histamine 
and skin prick testing were performed on randomly selected students from 
groups generated from questionnaire response, along with controls (those 
who had no past history suggestive of asthma or atopy). Histamine 
provocation and skin prick tests were performed on 157 students. Bronchial 
hyperresponsiveness was defined as a dose of histamine provoking a 20% 
fall in forced expiratory volume in one second equal to or less than 8|jmoles. 
Atopy was defined in a number of ways. 
Bronchial hyperresponsiveness was associated with atopy (however 
defined), diagnosed asthma, and respiratory symptoms suggestive of asthma 
within the past year. Not all diagnosed asthmatics with symptoms within the 
past year displayed bronchial hyperresponsiveness. All students with 
bronchial hyperresponsiveness had or had had a history of respiratory 
symptoms suggestive of asthma. The prevalence of diagnosed asthma from 
the first questionnaire was 4 .8% and the prevalence of respiratory 
symptoms suggestive of asthma ever was 45%. All diagnosed asthmatics 
had atopy (one or more response 2mm greater than or equal to the saline 
control). Students from Kwai Ghung and Kwun l o n g had a greater incidence 
of bronchial hyperresponsiveness and eczema or rhinitis, than those from 
Shatin and the Southern district. The prevalence of diagnosed asthma and 
bronchial hyperresponsiveness was greater in students born in Hong Kong 
than those born in China. Parental asthma history and bronchial 
hyperresponsiveness were not related, although of those with a parental 
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history 72% reported respiratory symptoms suggestive of asthma. 
Diagnosed asthma was more prevalent in males than females. No significant 
difference existed between the sexes for bronchial hyperresponsiveness. 
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1. Introduction 
1.1 The Problem 
The basic abnormality in the pathogenesis of asthma is not known. However, 
it is generally accepted that asthmatic airways are hyperreactive; that is they 
show an increased ease to narrow in response to a number of non allergic, non 
sensitising stimuli. Precisely defining a disease of unknown aetiology is difficult 
and as a result hampers accurate identification (1). In addition, several factors 
confound the detection of asthma in the community. Clinically, asthma 
overlaps with other respiratory diseases making clear distinction difficult: in the 
young similar symptoms may present with bronchiolitis and wheezy bronchitis, 
and in the elderly, chronic bronchitis and emphysema. Additionally, the 
transient nature of the disease makes diagnosis difficult as subjects may be 
symptom free, with normal lung function upon examination, at certain times of 
the day or year. Further, lifetime and current prevalence rates will differ. 
Investigators have created their own 'definitions' of asthma because there is 
no universally agreed definition or criteria by which asthma can be identified, 
which results in a number of diagnostic inconsistencies in similar populations 
《2). Until there is greater understanding of the disease, asthma is likely to defy 
definition. 
Recently objective measurements have been introduced to detect the increased 
responsiveness or hyperreactivity of the airways, and these tests have become 
useful in the diagnosis of asthma (3). Initially there was little disagreement that 
bronchial hyperresponsiveness (BHR) is an almost universal finding in current, 
symptomatic asthma (4), being frequently present in asymptomatic asthmatics. 
More recently the closeness of this association has been challenged with the 
finding that exacerbations of asthma may occur in the absence of increased 
BHR (5). BHR is not specific for asthma and consequently its presence should 
not necessarily qualify an individual as "asthmatic". BHR exists to some extent 
in other respiratory disease states with an inflammatory base, such as chronic 
obstructive airways disease (10.11.12), sarcoidosis (15J6 ) , and 
bronchiectasis (13,14). It has also been observed in smokers and during upper 
respiratory tract infections. Indeed it has been observed in seemingly normal 
individuals. However, it is undisputed that BHR is one important feature of 
asthma (6), although the precise relationship between BHR and asthma is 
unc6rt3i � . 
Atopy, the term used to describe a group of individuals who are hypersensitive 
to common environmental antigens, is another important feature of asthma. 
Further, antigen load is considered important for the development of asthma 
(7). Again however, the closeness of the association between atopy and 
asthma remains unknown. Many individuals who develop asthma in later life 
and a minority of younger patients fall to show any obvious signs of allergy (so 
called "intrinsic" asthmatics). On the other hand, whether a nonallergic 
asthmatic state actually exists has recently been disputed (8). BHR and atopy 
are also associated, although the exact nature of this association remains 
uncertain and no causal relationship has been shown. 
1.2 The Purpose of the Study 
The main objective of the study was to observe the relationship between 
asthma, BHR to inhaled histamine, and atopy in students of Chinese ethnic 
origin attending the Chinese University of Hong Kong (CUHK). Given the 
difficulty in defining asthma, both a past doctors diagnosis of asthma and 
respiratory symptoms suggestive of asthma (RSSA) including wheeze, exercise 
wheeze, tight chest, shortness of breath and nocturnal cough, were used. 
Further relationships between environmental factors and asthma, BHR, and 
atopy were also examined. 
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1.3 Study Design 
Questionnaires were used to determine the presence of RSSA, asthma 
diagnosis, and atopic symptoms. To establish the lifetime prevalence of RSSA 
and atopy a questionnaire (Ql) was administered to all potential first year 
CUHK students. To establish the prevalence of RSSA and atopy within the 
past year a further questionnaire (Qll) was sent to all those reporting lifetime 
RSSA. Prior to the study both questionnaires were tested for repeatability. 
Distinct groups of symptoms were generated from questionnaire results (Figure 
1). Questionnaires were administered and data collected and collated between 
August 1989 and October 1989, Following some sample size planning, 
computer generated random selection of students provided subjects for 
continuation in the study. All students gave informed consent (Section 4). 
Histamine inhalation challenge testing was used to assess BHR, and skin prick 
testing to detect atopy. Residential histories and additional information was 
obtained at the time of testing. Testing took place between November 1989 
and March 1990. 
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2. Literature Review 
2.1 Bronchial hyperresponsiveness 
BHR can be defined as an increase above normal in both the ease and 
magnitude of airway narrowing on exposure to a number of nonallergic or 
nonsensitising stimuli (4,9). Increased responsiveness of the airways to 
these physical, chemical and pharmacological stimuli is frequently observed 
in individuals with asthma. However, BHR does not occur exclusively in the 
asthmatic state. This phenomenon has been recorded in some individuals 
with chronic bronchitis (10,11,12); bronchietasis (13,14); sarcoidosis 
(15,16}; farmers lung (17); cystic fibrosis《18); and smokers (19). Transient 
increases in bronchial reactivity have also been documented during and 
following upper respiratory tract infections (20). Additionally, seemingly 
healthy individuals may display increased reactivity (21). It is not clear 
whether the BHR exhibited in these disease states has the same 
characteristics 3S those observed in the asthmatic state, or whether it is the 
nonspecific response of inflammed or hypertrophied airways, or a result of 
reduced airway calibre (22). 
Evidence exists to strongly suggest that airway inflammation plays an 
important role in the pathogenesis of BHR (23,24). Many of the stimuli used 
for experimental induction of airways hyperresponsiveness also produce an 
inflammatory response in the airways lending support that these two 
processes are linked. These stimuli include: ozone (25); viral respiratory tract 
viruses (26); and allergens (27). In animals, increased airway responsiveness 
is closely related to the degree of airway inflammation (28,29). In man it is 
not known how close the association is between the extent of airway 
inflammation and degree of BHR. Indeed, the main pathophysiological 
abnormality linking BHR and inflammation remains obscure, since symptoms 
of asthma may not be closely related to the degree of BHR (30). Further, the 
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mechanism by which inflammation of a specific type can lead to BHR is not 
known. It may be important, therefore, to include examination of the 
environmental risk factors associated with BHR and linked in some way with 
asthma, in epidemiological studies, (see section 2.4) 
2.12 Asthma, BHR and RSSA 
Asthma prevalence seems to vary considerably between countries and within 
countries. As stated, because there are no universally agreed diagnostic 
criteria for the diagnosis of asthma, comparison of rates has to be 
undertaken with caution. The hazards of comparison of asthma prevalence 
rates from different studies have been extensively reviewed (2). For valid, 
accurate comparison methods need to be virtually identical, it must be 
stated whether prevalence rates for asthma are current or lifetime, and 
studies under comparison ideally need to have been conducted at a similar 
time - given that prevalence rates in a given population will change with 
time. Asthma prevalence in the USA has been shown to vary with age (31). 
(Figure 2) The aetiology of asthma may not be the same for all countries so 
intercomparison of rates between different age groups should be undertaken 
cautiously. Few studies have adopted identical methodologies in exactly the 
same age groups at the same time. However, undoubtably general trends 
have been observed. Prevalence rates vary from a virtual absence in Gambia, 
(32) Nigeria, (33) Papua New Ginuea (34) and India (35) to over 12% in 
Australia (21), and higher still in New Zealand (35) and the Maldive Islands 
(36). Most recently in China the prevalence of diagnosed asthma was found 
to be 2.4% (37). Whilst there is a tendency for asthma prevalence to be 
greater in association with Westernisation, asthma is not exclusively a 
Western disease (2) as demonstrated by the high asthma prevalence in the 
Maldives (36) and Tanzania where the current asthma prevalence was found 
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to be higher than other underdeveloped countries (38). In young adults less 
data exist; in New Zealand asthma prevalence was 12.5%, (39) in Australia 
11% (40) and the USA 7.8% in 15-19 year olds (31). 
More recently prevalence rates for BHR have been documented. However, 
standardised protocols used for the detection of BHR in all subjects do not 
exist. A number of methods using a variety of challenge agents for the 
detection of BHR have been documented and are discussed in Section 5.3, 
as are the comparability of methods and agents. As with asthma an age 
dependent association may exist for BHR. Weiss (41) demonstrated that 
those aged 24 and under were significantly more likely to display BHR than 
those over 24 years of age. Similarly in younger subjects age significantly 
affects the prevalence of BHR (37). On the other hand, Trigg failed to 
observe a significant association of BHR with age in those aged 18-85years 
(42). 
The range of BHR prevalence as with asthma seems to vary between 
countries. In children using the same methods, BHR in China was found to 
be 4.1% (37), in Australia 17.9% (43) (but in slightly younger children) and 
20% in New Zealand (44). In young adults Cookson (40) defined BHR to be 
less than 15[jmoIe methacholine and found the prevalence of BHR to be 35% 
in Australian students. In Canada using different methodology the prevalence 
of BHR was 10.3% (45). In two general population studies in the UK 
adopting different methodologies the prevalence of BHR was 14% (19) and 
230/0 (42). In a similar general population age group in Australia, using 
comparable methodology to Burney《19》but with a lower cut off point the 
prevalence of BHR was 11.4% (46). Table 1 summarises prevalence rates 
from some important studies of BHR and asthma. 
IL^ 
The exact relationship between BHR and asthma is largely unknown. BHR is 
shown to be strongly associated with symptomatic asthma (21,37). 
However, it is accepted that asthma and BHR are not the same, and the 
prevalence of one does not accurately represent the prevalence of the other. 
Consistently BHR prevalence is found to be higher than the prevalence of 
asthma (21,37,46). There is difficulty in separating asthmatics from 
nonasthmatic subjects as overlap may exist between values measuring BHR 
in normal and asthmatic subjects (47) although the asthmatic subjects tend 
to be more reactive (48). Better discrimination is observed in those with 
symptoms. The concept that BHR is a universal finding in all symptomatic 
asthmatics at a given time is not accurate. Several studies have found an 
absence of BHR in the asthmatic state, as many as 50% of diagnosed 
asthmatics without BHR were found in one particular study (49). Even in 
exacerbations of asthma, BHR will not necessarily be present (5). 
RSSA have been shown to be significantly associated with BHR. Salome (21) 
et al demonstrated a significant association between wheeze, exercise 
wheeze and nocturnal cough, and BHR. However, the prevalence of wheeze 
or respiratory symptoms was lower than the prevalence of BHR. Zhong (37) 
also showed a significant association between BHR and the symptoms cough 
and wheeze, the prevalence of wheeze was, as Salome, lower than the 
prevalence of BHR - whilst the prevalence of any respiratory symptom was 
higher. These findings indicate that whilst an association may exist between 
symptoms and asthma it is incomplete. Weiss (41) failed to show any 
association between BHR and respiratory symptoms. Whilst although 
Enarson (50) showed that wheeze and breathlessness were closely 
associated with BHR, he concluded that symptom-based definitions of 
asthma failed to improve on physician based asthma because the question 
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presumed to elicit information most specific for asthma "attacks of chest 
tightness associated with difficulty in breathing" was not as closely 
associated with BHR. 
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2.2 Atopy 
The term atopy was introduced in 1923 by Coca and Cooke to describe a 
group of Individuals who were hypersensitive to common environmental 
proteins. Atopy is characterised by the development of antibody response of 
immunoglobulin E (IgE) following exposure to inhaled, ingested or injected 
antigens (allergens). Although measurements of IgE levels are sometimes 
used to assess atopic status, the standard means of identifying an allergic 
individual are allergy skin tests (51). Allergy to environmental proteins is 
common, one third of the population of Beijing were shown to have some 
form of allergic disease《52). 
Atopy is a clinical condition of which asthma is one component, other 
components include hay fever, rhinitis and eczema as well as other specific 
and non-specific allergic states. Other allergic disease states and their 
prevalence in a Chinese population are listed in Table 2 (52). 
Atopy and asthma were shown to be related by the early work of Coca and 
Cooke. Subsequent work has supported this association (53). Atopy is often 
regarded as a risk factor for the development of asthma《54). However, 
allergic factors may only be present in some asthmatics. Classically, asthma 
has been subdivided according to the presence or absence of recognisable 
allergic features, although the accuracy of such a broad characterisation of 
asthma is often disputed. Extrinsic asthma refers to those asthmatics who 
display signs of allergy. Often these individuals have rhinitis and/or eczema, 
and there is a tendency for this form of asthma to have an earlier onset than 
intrinsic asthma, the so called non allergic form of asthma. On the basis of 
skin prick testing, atopic and non atopic forms of asthma do exist (55). In 
Hong Kong children, over 90% of asthmatics displayed sensitivity to one or 
more allergen. (56 )ln a general population in Hong Kong (aged 3-69 years) a 
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similar rate of allergic asthma was observed (57). Recently, evidence has 
been provided that suggests that all forms of asthma have some kind of 
allergic basis (8). IgE levels and skin test reactivity in a large general 
population study asthma were nearly always associated with some kind of 
IgE-related reaction. 
Inhaled allergens can cause acute reversible airways obstruction in 
individuals with specific immediate hypersensitivity (58). There is evidence 
to suggest that antigen load is important for the development of asthma and 
atopy (7) Whether the atopic state is causally related to BHR is not clear. 
Sibbald et al (59) have suggested that BHR and atopy are separately 
inherited characteristics. However, there are reasons to suggest that atopy 
may be one of the causative risk factors for the development of BHR (45). A 
causal association is supported by the observation that increased bronchial 
reactivity follows allergen inhalation (27) and reduction in BHR occurs upon 
allergen avoidance (60). The combined effect of repeated allergen inhalation, 
naturally or experimentally, with subsequent mediator release and late 
reaction, may lead to the development of BHR (45,61). A common 
mechanism in the development of BHR and atopy is suggested by Peat et al, 
who observed that the severity of atopy is associated with the severity of 
BHR《62), and children with more severe asthma react more strongly and to 
a wider range of allergens than children with mild asthma. The authors argue 
further however, that there cannot be a causal relationship as 10% of 
nonatopic children had BHR, nearly two thirds of children had neither 
symptoms nor BHR and 50% of highly atopic children were asymptomatic. 
Evidence to suggest that the relationship between allergens and the 
development of asthma may not be simple, is provided by the observations 
that many individuals with extrinsic asthma do not notice a relationship 
^ 
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between respiratory symptoms and exposure to allergens. Further, many 
may develop nasal symptoms in the absence of respiratory symptoms. 
Additionally, many highly allergic individuals develop hay fever and rhinitis, 
but fail to develop clinical, symptomatic asthma (58). 
Epidemiological studies examining the relationship between atopy and BHR 
have produced conflicting results. Many studies display a significant 
association between the two traits (19,37,45,63), some however, fail to 
show an association (64,65), others demonstrate that the way atopy is 
quantified may determine whether an association exists, or not (54). 
Burney,(19) found that the relationship between BHR and atopy was 
negatively associated with age. Not only does skin sensitivity decrease with 
age, but also the association between skin sensitivity with BHR. Serum IgE 
levels reach their peak level during childhood then start decreasing with 
advancing age (8). This effect of age upon atopic status is further supported 
by Barbee's study (66). Although in the elderly, some of this decline in atopy 
with age may be explained by the fall in IgE, it is not thought to be the full 
explanation (51): both children and the elderly tend to show less allergy skin 
test reactivity than young adults. 
Within an atopic population it is the type of allergen and the quantity of 
aeroallergen present in the environment, together with the degree of atopy 
that may interact to increase the risk of BHR (62). Almost all allergens that 
give rise to immediate hypersensitivity are implicated in asthma and 
examples are shown in Table 3 (67). 
An exceptionally high number of atopic patients are sensitive to house dust 
and house dust mite. In Hong Kong 97% (57) - 100% (68) of atopic patients 
were sensitive to dust and dust mites. Elsewhere, sensitivity to dust mite 
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allergens in atopic individuals occured in 80% - Australia (69), 80% -
Zimbabwe (70), 85% - Japan (71), and over 80% - UK (72). Symptoms of 
asthma have been shown to increase at a time when increased levels of 
house dust mites were observed (68). 
In Hong Kong if allergens are grouped then the following occurrence rate of 
sensitivity in atopic individuals has been observed (57): house dust/house 
dust mites 100%; animals 80%; foods; 29%; moulds 22%; and pollens 
170/0. The results of all skin prick tests performed by the Pulmonary Function 
Laboratory (PFL) at the Prince of Wales Hospital (PWH) during 1989 are 
shown in Table 4. Of the 265 individuals tested during the year 71% had a 
suspected diagnosis of asthma, 13% were students in this study and 16% 
had other respiratory diseases. 
In summary, atopy is associated with BHR and asthma, and is one factor 
amongst others which predisposes to BHR (45). Asthma and BHR may be 
induced via a common inflammatory mechanism (73) and other risk factors 
associated with inflammation warrant investigation. These include: smoking; 
air pollution; and respiratory tract infections, see section 2.4. 
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2.3 Genetics & the Environment 
As early as the 12th century, the familial incidence of asthma was observed. 
Although the exact mode of genetic transmission is yet to be determined 
(74), the important role of genetic factors in the pathogenesis of both 
asthma (59,75) and atopy (75,76,77) has subsequently been confirmed. 
Atopy (as defined by an increased tendency to form IgE antibodies to 
common allergens) is inherited (77) and the inheritance of atopy occurs 
independently of asthma (59) and BHR (78). Sibbald (59) further suggests 
that although atopy does not predispose to asthma, it may enhance the 
genetic susceptibility to acquire the condition. Lebowitz (79), after 
controlling for age, sex, smoking and skin test reactivity, demonstrated a 
significant family concordance for circulating IgE levels and physician 
diagnosed asthma, wheeze and allergic rhinitis. A parental history of asthma 
has been observed in approximately 50% of children with asthma (43,80) 
and families of patients with asthma have a higher prevalence of BHR than 
controls (81). 
However, both family (78,82) and twin studies (76,83) whilst confirming the 
existance of genetic factors, have made clear the important influence of the 
environment in the expression of asthma and BHR. In fact, both twin studies 
showed incomplete concordance for BHR and asthma. Hargreave (4) further 
argues that there is little evidence for the widespread belief that BHR is 
genetically determined. He proposes that genetic factors could operate by 
determining the initial level of responsiveness or the predisposition to acquire 
BHR from appropriate stimuli. 
The powerful effect of environmental influences upon the occurrence of 
asthma in a genetically predisposed population is presented by Mantle and 
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Pepys (84) in their investigation of asthma amongst Tristan da Cunha 
islanders. The high incidence of asthma on this island derives from two or 
three asthmaitcs of the original 15 settlers of this highly inbred community. 
Despite the unchanged genetic endowment of the islanders, there has been a 
decline in the incidence and severity of asthma. The authors stress the 
importance of the multifactoral aetiology of asthma in this community. 
To date the vast proportion of epidemiological studies indicate with one 
important exception that asthma development is influenced by the 
environment (85). That exception is atopy. A number of population studies 
have studied the effect of migration upon the prevalence of asthma. The 
tendency of asthma to be more prevalent in Westernised than poorer 
countries has already been suggested. But as stated exceptions do exist, 
with the Maldives (36) showing a high asthma prevalence and the 
suggestion that asthma prevalence in Scandinavia is lower than other 
European countries (2). Large variations in asthma rates between similar 
populations in different countries have been recorded. Children born in India 
or Pakistan who migrated to England had a significantly lower prevalence of 
asthma than Europeans, or than Asian children born in England - who had a 
similar rate of asthma as the Europeans (86). But East African born Asian 
children had the same asthma prevalence as English children, the authors 
suggest that these children may have been exposed to a more Western 
lifestyle in East Africa than would have been In India (87). However, 
different races sharing a common environment do not necessarily display the 
same prevalence rates of asthma (2) which Indicates that environmental 
influences do not entirely account for prevalence differences. 
Burrows (88) suggests that because of the effects of the environment, the 
extent to which BHR is an inherited trait is difficult to determine. However, 
he proposed the following explanation: Some degree of BHR is present in 
virtually all infants (89) and some infants do show relatively poor lung 
function, these infants are at increased risk of developing wheezy illness 
later in infancy (90). Poor airway function is associated with a family history 
of wheezing complaints (91) and those in whom symptoms persist virtually 
always display an allergic predisposition (92). The factors that enhance the 
expression of this allergic predisposition in the lungs are probably related to 
environmental exposures. 
2.4 Environmental Influences 
2.41 Smoking 
Some 30 years ago it was proposed that smokers with chronic and largely 
irreversible airways obstruction shared a common allergic constitution and 
increased BHR with asthmatic patients - the so called "Dutch" hypothesis 
(93). 
It is widely agreed that middle-aged smokers with mild/moderate airways 
obstruction frequently display BHR when challenged with methacholine (94). 
The BHR observed in smokers is greater than in nonsmokers (64,95). There 
appears to be a strong inverse relationship in smokers between the intensity 
of BHR and reduction in baseline forced expiratory volume in one second 
(FEVi) (95,96). On the other hand others have failed to find an association 
between BHR and smoking (97). Indeed, Barter and Campbell observed that 
the number of cigarettes consumed was negatively correlated with 
methacholine reactivity (96). 
The presence of BHR in smokers may be age dependent. Taylor observed 
that the prevalence of BHR in smokers increases with advancing age, indeed 
younger smokers failed to display BHR (95). No significant difference 
between airways reactivity was found in young male smokers and 
nonsmokers (98). Further, young asymptomatic smokers have been shown 
to be less reactive to histamine than nonsmokers (99). 
Cigarette smoking Is associated with elevated levels of total serum IgE 
(100,101,102). However, raised levels of IgE may not necessarily reflect an 
increased prevalence of hypersensitivity to common aeroallergens as 
smokers have not necessarily been shown to have greater skin test reactivity 
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than nonsmokers (100). Taylor suggests that the allergic features displayed 
by smokers are less pronounced than those displayed by asthmatics (95). 
Nevertheless, atopic smokers may be at greater risk of developing BHR. 
O'Connor (100) proposes that smoking and atopy may act synergistically to 
increase the degree of BHR. Furthermore, smokers with an allergic 
disposition show an accelerated decline in lung function (103). 
Several authors have found an association between cigarette smoking and 
asthma and asthma-like symptoms. Welty (64), in a population study found 
cigarette smoking to be a significant and independent predictor of wheeze 
and asthma. Over a three year period the prevalence of current smokers was 
significantly greater among the subjects who developed asthma than those 
who did not, in the Dodge and Burrows population study (31). Burrows 
n 0 4 ) proposes that smoking could Increase nonspecifically the allergic 
inflammatory reaction of the airways seen in some allergic individuals, 
leading to an increase in asthma like symptoms in addition to BHR. 
The pulmonary changes brought about by smoking in individuals without any 
asthmatic-allergic type of predisposition bear little resemblance to those seen 
in asthma (104,105). 
2.42 Passive Smoking 
Passive smoking may be the most important source of environmental 
contamination (106). The potentially harmful effects of passive inhalation of 
cigarette smoke are documented. In children inhalation of parental cigarette 
smoke has been shown to enhance bronchial reactivity (107). O'Connor 
(108), failed to show this association in non-asthmatic children, however he 
did observe a significant increase in BHR in asthmatic children whose parents 
smoked. Murray (109), also found a marked increase in BHR in asthmatic 
children whose mothers smoked. 
Reduced lung function in the children of smokers is a frequent observation 
(107,108,110,111,112). Indeed, Ware (110) found a linear relationship 
between this reduction and daily cigarette consumption. Although the 
reduction in spirometric tests of children exposed to passive smoke in 
population studies is sometimes small (110,111) the decreases seen in 
asthmatic children are marked (113). However, reduced spirometric values in 
the children of smokers have not always been observed (114). Tager (115) 
analysed data from studies with conflicting findings on the effects of 
parental smoking on childhood pulmonary function. In East Boston an 
association had been found between maternal smoking and reduced FEV^, in 
Tucson no such asociation was found. Both studies were subject to identical 
methods of analysis. Post analysis the findings remained the same, with 
Tager concluding that climatic influences may combine and modify the 
response to passive smoke inhalation. 
An increased incidence of childhood respiratory illnesses in association with 
parental smoking are frequently reported (110,112,116). With wheeze being 
a symptom commonly reported in the children of smoking parents 
(117,118). Weitzmann (116) found an association between maternal 
smoking and the following: an increased likelihood of using asthma 
medications and an earlier onset of asthma. A similar association was found 
by O'Conneil (119) between childhood asthma and parental smoking. He 
further observed that the elimination of passive smoke brought about clinical 
improvement six months to two years later. 
Kershaw《120) has labelled passive smoking as the most important 
environmental factor in the aetiology of early asthma. Passive smoking 
worsens the symptoms of those with existing asthma: Murray (113) 
observed that asthamtic symptoms were worse if the mother smoked than if 
she were a nonsmoker. A age dependent association was observed: with the 
effects of passive smoking increasing with age and the number of years 
exposed to the mother's cigarette smoke (109,113). However, this age 
association is not a consistent finding (121,122). 
On the other hand, several authors have failed to demonstrate an increased 




Reports from Tokyo and Yokohama, New Orleans and Barcelona, reveal that 
localised increases in the prevalence and severity of asthma have occurred in 
well defined geographical locations. In 1954 an increased incidence of 
asthma was reported among United States military personnel stationed in the 
heavily polluted Kanto plain of Japan (125). Individuals wi th Tokyo-
Yokohama asthma generally experienced dramatic improvement upon leaving 
the area. Notably similar cases were not found in the indigenous population 
(126). 
In New Orleans City outbreaks of asthma have been reported for some years 
occurring predominantly during the period of September through November. 
Initial reports (127) suggest a link between the outbreaks and increased 
levels of air pollution. The same increase did not occur in patients wi th 
chronic bronchitis. Extensive air sampling over a period of years failed to 
show a consistent association between air pollution and the increased 
asthma incidence. Although the cause has not been established current 
opinion is that natural allergens may be responsible (128). 
Asthma admissions in Barcelona hospitals reached epidemic proportions on 
some 26 occasions during the period 1981-1986. (129) No association was 
found between levels of air pollution and the outbreaks. (130) Airborne dust 
released during soybean unloading is thought to be responsible for the 
outbreaks. 
Anderson provides further strong evidence against a close association 
between general increases in air pollution and asthma (131). His report 
describes a virtual absence of asthma in an environment containing high 
levels of air pollution. 
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The possibilty that air pollution may enhance the expression of atopy in the 
lungs and consequentially increase the risk of BHR is raised by Dockery 
《132>. Indeed, Kagamimori (133) has reported that children with atopy (as 
defined by positive skin reactions) in a polluted area near power stations 
have a higher prevalence of sub-acute cough, sub-acute phlegm and 
wheezing. Following anti-pollution measures and consequential decline in the 
concentrations of sulphur oxide (SO?), nitrogen dioxide (NO?) and suspended 
particles, a reduction in the prevalence of respiratory symptoms among 
schoolchildren in the same area occurred (134). 
The most widely encountered air pollutants are SO2, NO2 and ozone. SO2 
levels in the atmosphere result from the combustion of solid and liquid fuels, 
nitrogen dioxide results from automobile emission and tobacco smoke which 
are the precursors of ozone. When encountered in the epidemiological setting 
it is difficult to distinguish their effects from each other and from other 
influences, such as cigarette smoke; climatic changes; age; social class; 
occupation etc. However, when used as challenge agents all have 
individually been shown to have adverse effects upon airway function. 
The bronchoconstrictor effects of SO? are established. In healthy individuals 
the inhalation of SO? has been shown to increase airways resistance (135). 
Asthmatics display particular sensitivity to the bronchoconstrictor effects of 
SO2 (136,137). An increased incidence of asthma was reported by Zeidberg 
(138) in association with high sulphate levels in the atmosphere. But others 
have failed to support this finding (139). No direct causal relationship 
between SO2 and asthma can be deduced - evidence for the association is 
largely anecdotal (140). 
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The inhalation of ozone can increase bronchial reactivity in healthy 
individuals (25,141) and worsen BHR in those with preexisting BHR (142). 
Additionally, Holtzmann (25) observed that atopic individuals were more 
sensitive to ozone than nonatopics. Furthermore during controlled exercise 
performed by healthy Individuals in levels of ozone encountered in urban air, 
reports of cough, substernal discomfort and reduced vital capacity (VC) and 
FEVi, increased airways resistance and decreased lung compliance have 
been recorded (143,144). However the effects of ozone upon airway 
narrowing may not be as pronounced as those produced by SO2 (145). 
In the healthy exercising individual exposed to NO:, no significant changes in 
pulmonary function were observed and were certainly less severe than those 
produced by ozone (146). The concentrations required to produce respiratory 
symptoms are much higher than those encountered in ambient air pollution 
eplsodes(146). In asthmatics, on the other hand, Orehek has shown that 
realively low levels of NO2 can lead to changes in airways responsiveness 
(147). 
From the literature no direct causal realtionship between air pollution singly 
and asthma can be assumed. 
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2.44 Upper Respiratory tract infections 
Transient increased responsiveness of the airways to certain physical stimuli 
following upper respiratory tract infection (URTI) in previously normal 
individuals has been observed (11,20,148,149). This heightened 
responsiveness may persist for several weeks after clinical recovery (20). 
Although BHR following URTI has been observed, some have failed to show 
any association in college students (150), schoolchildren (43) or adults 
(151). 
It is a widespread belief that URTI in childhood may trigger asthma (152). 
From the literature it is a common observation that viral respiratory tract 
infections are frequently precipitants of wheezing in young children. It has 
been proposed that viral infections (most notably respiratory syncytial virus, 
RSV) may be one of the factors capable of converting the genetically 
predisposed child into an asthmatic (74). Of children with a history of 
infantile RSV bronchiolitis, 56% subsequently developed asthma (92). The 
children who developed asthma had a significantly higher prevalence of 
asthma amongst their relatives, than the children who did not develop 
asthma. Further associations between infantile RSV bronchiolitis and 
subsequent wheezing have been found (153). Moreover, in a study of eight 
year old children Pullen (154) showed that of 130 children with infantile RSV 
infections, 42% had further episodes of wheezing when compared with 19% 
of controls. A three-fold increase in the incidence of BHR in the RSV-lnfants 
was noted, when compared with the controls. Early respiratory illness was 
found to have an important association with BHR in the Australian study of 
2,363 schoolchildren (43). 
Despite the above observations, there is no concrete evidence to date to 
prove that URTI will cause asthma in previously normal individuals (155). 
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There are important exceptions to these observations.The absence of asthma 
in children under 10 years in the Papua New Ginuea highlands where the 
incidence of URTI was four-times higher than the rate for 7 year old children 
in UK suggests that the role of infection in the pathogenesis of asthma may 
be a secondary one (34). 
There is no real difference between the incidence of acute respiratory tract 
infections in developed and developing countries (156). There are however 
striking differences in mortality rates:on a global scale mortality in children 
from respiratory tract infections is some 30 times greater in Egypt, Paraguay 
and Mexico than in Canada or the USA (157). The Incidence of asthma 
appears to be higher in developed rather than developing countries, which is 
not what one would expect if infections play a primary role in the aetiology 
of asthma. 
Respiratory infections are important stimuli to induce asthma attacks (6,152) 
and may prolong recovery (152). Despite early beliefs that bacteria may be 
asthmogenic, bacterial infections seem to be better tolerated than viral, 
despite the fact that the degree of airway inflammation caused by bacterial 
infection is greater than that caused by viral (6). It is generally regarded that 
there is insufficient evidence to link bacteria to exacerbations of asthma (73). 
The evidence linking viral infections with exacerbations of asthma is 
stronger, particularly in children. Viruses have been isolated from children 
during episodes of wheezing, although no virus or group of viruses have 
been identified as being more asthmogenic than others (117). 
The incidence of exacerbations of asthma associated with respiratory tract 
infections in adults varies. Kava (152) observed that about 25% of 
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exacerbations occured with symptomatic respiratory tract infections. 13% of 
asthmatic exacerbations in Megueres (158) study were associated with viral 
and non-bacterial infections. 
Not all investigators argue for an association between infections and 
exacerbations of asthma. Viral respiratory infections may not necessarily 
increase airways responsiveness in asthmatics (151). Asthma epidemics as a 
consequence of climatic changes rather than infections have been proposed 
(159,160). 
Whether killed virus vaccines alter airways reactivity is under dispute. The 
outcome of studies examining the relationship may depend upon vaccine 
strains used and methodological differences (152). Airways responsiveness 
to histamine was not affected by vaccination with killed influenza vaccine in 
the studies by Kava (152) and DeJongste (161), whereas increase in 
bronchial reactivity was observed by Banks (162). Live attenuated influenza 
virus vaccines has been shown to cause transient increased bronchial 
reactivity to histamine (153). 
The development of atopy may also be influenced by viral respiratory tract 
infections. Frick has observed that the clinical and immunological evidence of 
allergy in children usually coincides with or follows within weeks of a URTI, 
commonly with parainfluenza virus or RSV (163). Welliver confirms this 
observation of a link between RSV and allergy (164). Others however have 
failed to show such associations (153,154). 
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3. Hong Kong (165) 
At the end of 1990 the population of Hong Kong comprised 5,859,000 
people. The total land area of Hong Kong is 1,075 square kilometers, 
making Hong Kong one of the most densely populated areas in the world. 
The overall population density per square kilometer was 5,430 people. 
However, the density of the population in the metropolitan areas was as 
much as 20,300 people per square kilometer. 
The climate in Hong Kong Is subtropical with a temperate weather for half 
the year. Temperature, humidity and rainfall for July 1989 to June 1990 
are shown in Figure 3. 
Air pollution is considered to be a major problem in Hong Kong. The main 
causes of air pollution are exaust fumes from incinerators, factories using 
high sulphur fuel, power stations and smoky vehicles. Dispersal of air 
pollution is limited by the hilly terrain and the high density, high rise 
housing. In some weather conditions the fumes emitted Hong Kong's 
industry are not dispersed which on occasions leads to a brown smog 
layer over the city. Government estimates (165) are that over half the 
population are exposed to undesireable levels of air pollution. Sulphur 
containing fuel is widely used in the territory, although only gaseous fuels 
have been permitted in Sha Tin for a number of years. At commencement 
of the study in 1989, the Government's report stated that the air quality in 
Hong Kong was deterioating. 
4. Ethical approval 
Approval of the study was granted by the Chinese University of Hong 
Kong Ethics Commitee following submission of a protocol prior to 




5.1 Subjects and study period 
First year, full time, undergraduate students of Chinese ethnic origin entering 
the CUHK were enrolled in the study (N = 1659). The geographical 
distribution by district of residence of the students is shown in Table 5, and 
compared with the distribution of the population of Hong Kong aged 15-24 
years. The broad geographical distribution is as follows: 21.1% Hong Kong 
Island' 46.9% Kowloon and 31.5% the New Territories. 
The study period was from August 1989 to March 1990. Bronchial 
provocation and skin tests took place between the end of November 1989 
and March 1990. 
5.2 Ques tionnaires 
The use of a questionnaire to detect respiratory symptoms in epidemiological 
studies of asthma is well established (19,21,37,46). Questionnaires are 
particularly useful when large numbers are being screened, and when the 
disease under investigation is transient, thus subjects may be symptom free 
upon initial, noninvasive medical examination. However, studies where only 
the questionnaire is used to identify asthma may well underestimate the 
prevalence of the disease (83), additionally, the questionnaire alone is not 
adequate to diagnose BHR in populations (167). Furthermore the same word 
may mean different things to different people. 
A closed, self administered questionnaire was thought preferential to open 
questions and interview for the reasons outlined by Stolley and 
Schlesselman, (168) which are summarised in Table 6. 
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Questionnaires should be both reliable and valid. A questionnaire is valid if it 
measures what it claims to measure. A relaible questionnaire is one that 
collects information that is replicable (168). The questionnaire used by 
Salome et al (21) has been well used and fulfills the above criteria. The 
questionnaires for this study was therefore based upon that of Salome et al 
(21). Further tests for repeatability were thought necessary because unlike 
the Australian study, English is the second language of subjects in this 
study. The reliability of a questionnaire can be measured by repeated 
completion of a questionnaire and comparing the responses given on the first 
and second administrations (168). This was undertaken in a pilot study of 65 
subjects taken from the CUHK, before the main study. Minor modifications 
were made before the second administration, therefore a third administration 
was made six weeks following the second administration and the 
repeatability calculated from the responses on the second and third 
administrations. Subjects were not warned about the repeated 
administrations. To ensure that no cases were missed, students were asked 
to record 'Yes' if they were unsure of any answer. 
Two questionnaires were used for the study. Questionnaire 1 (Q|) 
established the lifetime prevalence of respiratory or atopic symptoms. 
Questionnaire 2 (Qll) established the current prevalence (within the past 
year) of the same symptoms. (Appendix 2) 
All first students accepted to study at CUHK were sent Ql along with the 
standard University Health questionnaire, via the University Health Centre, in 
July1989. Questionnaires were returned with the University Health 
Questionnaire to the Health Centre. Students who had deferred entries into 
CUHK did not receive Ql and were therefore not included in the study. All 
those who had recorded a positive response to any RSSA were sent Qll once 
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term had commenced (October/November 1989). Qll was sent via student 
faculties or departments, or to student homes if the afore mentioned details 
vv6r6 unknown. 
Students were then divided into groups according to their response to the 
questionnaires and then cases were randomly selected by computer for 
continuation in the study, (see 1.3 Study Design) The randomly selected 
cases, and controls were invited to attend the Prince of Wales Hospital 
Pulmonary Function Laboratory for bronchial provocation and skin testing, 
after giving informed consent. Prior to testing additional questions were 
asked and are shown in appendix 3. 
5.3 Bronchia! provocation 
Tests of airways responsiveness are frequently used for the assessment of 
respiratory diseases (3,169). Bronchial provocation tests are particularly 
useful in � i demio log ica l studies of asthma, allowing objective comparisons 
which may reflect the prevalence, nature and severity of asthma in the 
different populations (22). However, a number of methods for bronchial 
provocation have been described (63,170,171) and a number of factors 
must be controlled for to interpret results and allow valid comparisons. 
5.31 Agents for provocation 
Provocative stimuli can be catergorised into specific and nonspecific. A 
specific agent is one to which an individual is already sensitive, eg, an 
individual allergen or occupational inhalants. A nonspecific agent will 
produce a response in most individuals with airways inflammation. 
Nonspecific agents can be pharmacological, (eg, histamine or methacholine) 
irritant, (eg,S02, citric acid) or physical (eg'exercise, hyperventilation). The 
airways response to different agents may be brought about by different 
38 
mechanisms: thus the relationship between BHR and asthma may be affected 
by the nature of the stimulus (172), although some provoking stimuli do 
appear to generate comparable responses, as demonstrated by Juniper with 
histamine and methacholine (173). Methods of bronchial provocation using 
Inhalation of histamine and methacholine are the best validated and most 
used in clinical and epidemiological work (174). 
5.311 Histamine 
The bronchoconstrictor properties of histamine have been long known. It has 
been proposed that when histamine is inhaled the mechanisms by which it 
causes bronchoconstriction may be both a direct effect on bronchial smooth 
muscle - via histamine receptors - and a reflex effect mediated by the vagus 
nerve. In healthy individuals the local effect may dominate and in individuals 
with airways inflammation the reflex effect may dominate (20). 
5-312 Guidelines for the storage and preparation of histamine 
Guidelines for the storage and preparation of histamine diphosphate solutions 
used for bronchial challenge have been outlined (175) and summarised: 
Histamine solutions of concentrations between 2.76mg/ml and 22.1 Omg/ml 
when kept in a cool place (12° C) can be maintained for four months; lower 
concentrations can only be maintained for two months; solutions should be 
prepared and maintained in sterile fashion. (See 5.34 for study preparation of 
histamine.) 
5.32 Route of administration 
Challenge agents can be administered via systemic or inhaled routes. The 
preferred route being inhaled because side effects may occur with systemic 
administration before the required dose necessary to evoke a response in the 
lungs is reached. In addition, systemic adminstration may affect other organs 
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and evoke reflex responses, that in turn may affect bronchomotor tone. For 
example, a drug causing a fall in blood pressure and a reflex sympathetic 
response may affect airway calibre (176). Additionally, drugs adminsitered 
systemically may be inactivated during their passage to the lungs (177). 
Although, theoretically the dose of drug delivered wi th systemic 
administration can be more accurately measured, the exact dose reaching the 
lungs may be more obscure for the afore mentioned reasons. Differences in 
the route of administration of challenge agents may determine whether the 
small or large airways are affected (3). Agents reaching the pulmonary 
circulation ( and hence peripheral airways) may evoke a different airways 
response than agents administered to the bronchial circulation (and hence 
large airways) or inhaled as aerosols of large particle size, which are 
deposited in central airways. For example, the main effect of intravenous 
histamine is constriction of peripheral airways, whereas the main effect of 
histamine delivered to the bronchial arteries is constriction of the central 
airways. 
5.321 Inhalation provocation tests 
Several technical factors may influence the amount and distribution of drug 
delivered to the lungs by inhalation and need to be standardised for any 
challenge procedure. These are summarised in Table 7《178). 
A number of different nebulizers have been used to generate aerosols in 
bronchia丨 provocation tests. Whilst the particle sizes from most nebulizers 
are suitable for inhalation (179), the output, in terms of dose delivered to the 
subject will vary considerably depending upon the nebulizer type and f low 
rate used. The nebulizer output is an important determinant of response to 
inhaled histamine and methacholine (179). Thus the output of a nebulizer 
must be known in order to calculate the amount of drug delivered to the 
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subject. The inspiratory flow time and rate are further important 
determinants of response : a reduction in time, and hence increase in rate, 
results in a lower total lung dose and higher provocation concentration or 
dose causing a 20% decrease in FEV] (PC20/PD20) (179). 
The extent to which particle size influences response to challenge agents is 
subject to debate. Ryan (179) concluded that measurement and 
standardisation of particle size may not be important for the standardisation 
of inhalation tests. A change in particle size did cause change in distribution 
of aerosol in the lungs, but failed to alter response leading to the further 
conclusion that it is dose rather than deposition that affects response. This is 
not a consistent finding. Ruffin (180) found that when deposition of aerosol 
occurred in the central airways (rather than peripheral) a 15 times smaller 
dose was required to produce the same response. Different methods of 
inhalation provocation tests have been compared (181). Tidal breathing with 
a Wright's nebulizer (63) was compared with a Devilbis 646 nebulizer 
attatched to a breath activated dosimeter (182). Both methods deposited the 
same dose in the lungs, however the distribution of the dose was different, 
despite this the PD20 obtained with each method was the same and the 
reproducibility of all measurements in the same subjects similar. 
5.33 Parameters used to measure response and expression of results 
There are no direct methods for measuring airway calibre. Changes in 
respiratory function in response to challenge proceedures can be recorded by 
use of several measures of airflow obstruction: F E V � � forced expiratory f low 
rates between 25% and 75% of vital c � a c i t y (FEFR 25.75)� maximum 
expiratory f low at 50% of vital capacity (FEF50); peak expiratory f low rate; 
specific airways conductance (SGaw); vital capacity《VC); and function 
residual capacity (FRC). Suggested guidelines for identifying a significant 
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change in each of the lung function tests have been delineated, but not 
validated, and are listed in Table 8 (169). 
The most commonly adpoted lung function measurements for challenge 
proceedures are FEV^ and SGaw (3). Theoretically, measurements of SGaw 
may be preferable to measurements of FEV】，because the former do not rely 
upon deep inspiratory manouvres. In individuals with asthma, a deep 
inspiration may transiently alter bronchial tone. Bronchodilation has been 
observed in some asthmatics post maximal inspiration (183). Conversely, 
bronchoconstriction has been documented in some asthmatics following 
deep inspiratory manouvres (184). However, in a comparative study of 
FEVi and SGaw as measurements of airways responsiveness to histamine, 
both were shown to be equally reproducible (185). Given this equal 
reproducibility, the authors concluded that measurements of FEV^ were 
preferable for the following reasons: 
i) There was better separation between asthmatic and normal 
subjects using FEV-, 
ii) FEVi is measured with more portable, less expensive equipment 
iii) FEVi is easier for the subject to perform. 
Fish (186) suggested that although SGaw is a slightly more sensitive test _ 
allowing detection of significant changes in lung function at lower doses of 
provocation agent - the advantages of this may be offset by the simplicity of 
FEV-i measurements. 
Bronchial responsiveness to histamine or methacholine is most frequently 
expressed in terms of the PC20 or PD20 of the challenge agent causing the 
fall in lung function (63) (Table 8). The change in lung function is measured 
as a fall from the post saline value, and the most accepted methods plot the 
inhaled dose of agent on a logarithmic scale (to stabilize variance) against 
this fall. The dose given is usually expressed in umoles or mg/ml. 
5-34 Preconditions for bronchia!provocation testing - nontechnical factors 
There are a number of nontechnical factors that may influence response to 
challenge agents. The preconditions for bronchial provocation testing are 
listed in Table 9. 
Subjects or controls who had had a cold within the past month were asked 
to return one month after the cessation of their symptoms. Colds were 
defined as Kava (152) if at least two of the following symptoms were 
present for two or more consecutive days after having being absent for at 
least 4 days: fever; sore throat; rhinitis. 
5-35 A rapid method for measurement of bronchia! responsiveness (170) 
For large studies the method for testing bronchial responsiveness should be 
reproducible, rapid, portable and easily understood by subjects. Yan et al 
(170) have described such a method using histamine as the challenge agent. 
Their method is highly reproducible (170,187) and has been widely used in 
epidemiological studies. This method was adopted for the study, BHR was 
considered to be present when the PD^qFEVi was ^ Sumoles histamine, as 
Burney (19). 
5.351 Nebulizer output 
Ten hand operated DeVilbiss No 40 nebulizers were used to administer 
histamine and saline to the subjects. Prior to the study the output of the 
nebulizers was calculated. Saline (2mls) was placed into the nebulizer, 
stoppers placed in the holes, and the nebulizer weighed. Following removal 
of the stoppers the nebulizer was squeezed firmly 10 times. The stoppers 
were replaced and the nebulizer reweighed. This was repeated 10 times for 
each of the nebulizers on two consecutive days and the mean volume 
delivered per squeeze calculated. Five nebulizer units were required for each 
challenge test procedure. 
5.352 Histamine solution preparation 
Solutions containing 5 g histamine in lOOmIs normal saline (5% histamine 
solution) were prepared and frozen by pharmacy. Each week solutions of 
0.3%, 0.6%, and 2.5% were made by serial dilution with normal saline 
under sterile conditions. Preparation of solutions were performed and 
checked by 2 individuals. � 
5.353 Lung function measurement 
Baseline FEV] and FVC were measured using a Vitalograph dry spirometer, 
which were calibrated prior to and at regular intervals during the study 
period. Student's heights were measured and their predicted lung function 
for age and height were calculated (188). Lung function was performed until 
two FEVi readings reproducible to within 200ml were obtained the highest 
of which was recorded on the study chart (Appendix 4). If satisfactory 
readings were not obtained after five attempts the test was abandoned. 
5.354 Challenge procedure 
After baseline lung function was established, the subject inhaled three 
breaths from the normal saline. The subject exhaled to slightly below FRC 
prior to inhalation. The mouthpiece of the nebulizer was placed just outside 
the open mouth of the subject and firmly squeezed as the subject 
commenced an inspiration over 1 to 2 seconds to total lung capacity (TLC), 
where the breath was held for 3 seconds. After 60 seconds the FEV^ was 
measured and the higher of two values that were reproducible to within 
200mls were recorded. The subject then followed dose challenge proceedure 
A as Yan et al (170) (Table 10), although doses 1 and 2 were combined. The 
challenge was stopped when the FEV] fell by 20% or more from the post 
saline value or when the maximum dose of 7.8|jmoles was reached. 
Controls, those who had no past history of respiratory illness, followed 
schedule B, but changed to schedule A if a fall of > 1 0 % and < 2 0 % 
occurred post histamine inhalation. Salbutamol via a metered dose inhaler 
and spacer device was given to aid recovery if a fall in FEV^ of 10% or 
greater was recorded at the end of the challenge. 
5.4 Measurement of atopic status 
Methods of detecting sensitisation can be divided into techniques that 
challenge the subjects tissues with allergen and those that detect IgE 
antibodies in serum (189). Tissue challenges consist of placing allergen on 
the skin, or mucosal surfaces of the nose, conjunctiva or lungs. Skin testing 
has been used for over 100 years in the diagnosis of allergic diseases. The 
skin, described as a "mirror of immunological changes" resulting from 
exposure to antigens (190) is thought to give an accurate reflection of 
allergic status. The allergic responses produced by skin testing have been 
described and classified (191) (Table 11). 
In atopic subjects, type I, immediate reactions to skin tests are mediated by 
IgE. The reaction develops in minutes, reaches a maximum after 10-20 
minutes and takes about 1.5 to 2 hours to resolve. The urticarial weal and 
flare response (often with itching) is a result of increased arteriolar f low 
through permeable capillaries, which leads to exudation of serum and 
production of oedema (191). Positive epicutaneous tests are thought to have 
good clinical relevance (192). Additionally, skin reactivity has been shown to 
correlate with serum IgE levels (51,193). 
Skin testing can be performed by either epicutaneous (scratch, prick or 
puncture) or intradermal methods. There are a number of reasons why 
epicutaneous skin testing is preferable to intradermal (189): i) there is more 
danger of systemic reactions to the allergen, because a larger volume is used 
and the risk of rapid absorption greater;") the intradermal method is more 
painful and slower to perform. These disadvantages make the use of 
intradermal skin tests in epidemiological studies impractical. 
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To allow comparison of skin test results a number of factors need to be 
standardised. (Table 12) 
Systemic antihistamines were withheld for a minimum of 48 hours before 
testing. Allergens used were house dust; Dermatophagoides farinae; D. 
pteronyssinus; Aspergillus fumigatus; egg; dog hair; cat hair; and pollen. 
Histamine and saline were used as positive and negative controls 
respectively. 
The method adopted was as Pepys (191). The volar aspect of the forearm 
was used. After skin cleansing, a grid was marked out on the forearm and a 
drop of each allergen and each control was placed on the skin. {Appendix 5) 
The point of a sterile lancet was inserted into the superficial layers of the 
epidermis, lifting it slightly but not drawing blood. A new lance was used for 
each allergen. Excess allergen was blotted off immediately. The mean weal 
size was recorded after 10 minutes. 
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6. Expression and analysis of data 
The measurements of repeatability used to assess the degree of 
reproducibility of the questionnaire were Kappa (194), proportion in 
agreement, and average correct classification rate (195). 
The output of the nebulizers was compared with that of Yan et al (170) by t-
test and Mann Whitney. 
A dose response curve was obtained for each test by plotting the FEV^ 
against the logarithmic dose of histamine. A maximum dose of 7.8^moles 
was delivered, but extrapolation of the dose was allowed to S.O^moles. 
Subjects with a PDsoFEV】 of 8 .0�moles or less were defined as having BHR. 
The degree of BHR was graded: 
Severe PD20FEV1 <0 .1 umoles 
Moderate PD20FEV1 ^ 0 . 1 < 0.8 umoles 
Mild PD20FEV1 > 0 . 8 < 3.2 umoles 
Slight PD20FEV1 � 3 . 2 � 8.0 umoles 
The individual PD20 values were also recorded and used for statistical 
analysis. 
RSSA were graded according to when the symptom last occurred using 
information obtained from Qll. Two measures of symptom severity were 
adopted for analysis: 1) If a symptom had occurred within the past month It 
was considered more severe. 2) Scores were given for when the symptom 
last occurred and the frequency with which the symptom occurred thus: 
Score 3 for symptom within the past month 
Score 2 for symptom within past 2-6 months 
Score 1 for symptoms within past 7-12 months 
plus Score 3 for frequent symptom 
Score 2 less frequent symptom 
Score 1 for infrequent symptom 
plus Score 1 for positive response to question 4. 
The sum of which gives the symptom score. The higher the score the more 
severe the symptoms. 
Atopy was defined in several ways: 
Index 1 • The number of positive responses to allergens 2mm � ^ the saline 
control; 
Index la ^ 1 positive response 
Index 1b ^ 1 positive responses 
Index 7c ^ 3 or more positive responses 
Index 2. The number of positive responses to allergens the histamine 
control; 
Index 2a ^ 1 positive response 
Index 2b ^ 2 positive responses 
Index 2c > 3 or more positive responses 
Index 3. (62) The sum of the number of groups* of allergens to which a 
positive response (2mm greater than or equal to the control) occurred; plus 
"1" for a response < 4mm and plus "2" for a response > 4mm. 
* Groups of allergens : G r o u p ” house dust, D.pteronyssinus, D. farinae 
Group 2: dog, cat 
Group 3: pollen 
Group 4: aspergillus 
Group 5: egg. 
Index 4. The sum of all responses to allergens 2mm > than the saline 
control. 
Air quality was categorised as 'good' and 'bad’. Kwun Tong and Kwai 
Chung were considered 'bad' having the highest air pollutant levels, and Sha 
tin and Southern district were classified as，good, wi th the lowest pollutant 
levels for Hong Kong, as advised by the Environmental Protection 
Department Air Quality Control Group (personal communication EPD). 
Analysis of data was performed using % \ Mann-Whitney, Fisher's exact 
test, and Spearman correlation coefficient. ” 
7. Results 
7.1 Repeatability of questionnaires 
Sixty students completed the questionnaire on the second occasion and 51 
on the third' giving a response rate of 79%. The questionnaires showed a 
high degree of repeatability (Table 13). 
7.2 Results of questionnaires 
7.21 Lifetime sypmtoms 
A total of 1,610 students completed and returned QI. This represents 97% 
of the first year undergraduate students. The results from QI are shown in 
Tables 14 and 15. A total of 724 (45%) students reported the occurrence of : 
one or more of the following RSSA at some time In their lives: wheeze; 
exercise wheeze; tight chest or shortness of breath; nocturnal dry cough; 
nocturnal wheezing, coughing or shortness of breath. Six hundred and 
twenty-eight students (39%) answered "no" to all questions. The majority of 
the remaining students (215, 13.4%) recorded either eczema, rhinitis or both 
in the absence of RSSA, parental history of asthma or childhood respiratory 
disease. Ten students reported eczema or rhinitis or both with a history of 
parental asthma or childhood respiratory disease or both, six reported 
childhood respiratory disease alone and 17 parental history of asthma alone. 
The prevalence of wheeze was 15.3% of the total population and exercise 
wheeze, 30.5%. Of those claiming to have experienced exercise wheeze, 
39.3% reported this as their only respiratory symptom. Only 15 students 
reported wheeze as their sole respiratory symptom, representing 6% of 
wheezers. A dry nocturnal cough was not reported as a sole past respiratory 
symptom. 
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The symptoms exercise wheeze and nocturnal symptoms (other than dry 
cough) - wheeze, SOB and cough were more commonly reported by females 
than males. (60% versus 39.5%, and 57.1% versus 42.9%). 
The prevalence of doctor diagnosed asthma was 4.8%, 60.3% of whom 
were male and 39.7% female. Three students who had a diagnosis of 
asthma claimed not to have taken any medication. There was a discrepancy 
between those who had taken medication for asthma (n = 85) and those who 
had a diagnosis of asthma (n � 7 8 ) . With one exception all those who 
reported having taken asthma medication in the absence of a diagnosis had 
had RSSA, implying that it is likely that they did have asthma. The one 
exception did not report having had any symptoms suggestive of asthma or 
atopy, therefore may have misclassified the drugs he had taken in the past 
as being for asthma. 
Seventy-two percent of those with a parental history of asthma had had 
RSSA or atopy, or both. Of those with diagnosed asthma, 10 (13%) had a 
parental history of asthma. Wheeze was reported by 23% of those whose 
parents had had (or currently have) asthma. Fifty-six percent of those 
recording parental asthma had had rhinitis or eczema. 
Symptoms of atopy (eczema/rhinitis) were reported by 71% of those with a 
diagnosis of asthma. Childhood chest trouble was reported by 7% of aii 
students. Of those with a diagnosis of asthma 44% consulted a doctor with 
some form of chest trouble before 16 years of age. 
7.22 Symptoms within the past year (Qll) 
Of the 724 students reporting lifetime RSSA, 593 (82%) completed and 
returned the second questionnaire on current symptoms (Table 16). Of 
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these, 317 (53.5%) reported the occurence of RSSA within the preceeding 
year and 105 (17.7%) reported symptoms suggestive of atopy 
(eczema/rhinitis) in the absence of RSSA. One hundred and seventy one 
(28.8%) had been symptom free for the past year. 
Wheeze occurring within the past year was reported by 12.5% of responders 
and prevalence was equally distributed between sexes (Table 17). However, 
as with lifetime symptoms more females reported exercise wheeze than 
males (62% versus 38%). Of those reporting wheeze, 40.1% reported that 
the wheeze occurred within the past month (Table 18). The point prevalence 
(occuring with in the past month) of wheeze was 5.1% of responders. Only 
1o/o of the total responders(or 8.1% of those reporting a current wheeze) 
reported more than 12 attacks of wheezing within the year.The majority, 
52/74, reported less than four attacks of wheezing during the year. Of those 
who reported wheeze, 8.1% said it was their only respiratory symptom. 
Sixty nine per cent of those who reported wheeze reported seasonal 
variation in severity. Of these 9.8% recorded that the wheeze was worse in 
the spring, 25% during the summer, 17.7% in the autumn and 39% in the 
winter. 
The incidence of exercise wheeze occurring within the past year was 33.7%. 
Sixty three percent of these reported this symptom within the past 
month.The point prevalence (within the past month) of exercise wheeze was 
21 %. Of those reporting exercise wheeze 51 % said it was their only RSSA. 
Seventeen per cent of responders reported signs of breathlessness or a tight 
chest occurring within the past year. Of these 34% reported occurrence 
within the past month. The point prevalence of SOB or tight chest was 
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5.70/0. One per cent of total responders (5.9% of those reporting these 
symptoms) reported more than 1 2 occurences within the past year. Of those 
reporting SOB or a tight chest 34% said these were their only RSSA. 
Dry nocturnal cough was reported by 110 students(1 8.6%), 49% of whom 
reported it as their only RSSA. Rhinitis and eczema were reported by 21.1% 
and 35.8% respectively. 
7.23 Classification of groups for random selection 
From both questionnaires 5 distinct groups of students were obtained for 
continuation in the study (Figure 4) and are classified thus: ” 
Ml. RSSA- past year, with or without atopy 
N2. Lifetime history of RSSA, none within past year, but with atopy 
symptoms -past year 
N3. Llifetime history of RSSA. No RSSA/ atopy - past year 
N4 No RSSA ever, but symptoms suggestive of atopy (lifetime or past year). 
N5 No RSSA or atopy ever, (controls) 
7.3 Nebulizer output 
The squeeze activated output of each of the ten nebulizers, which was 
checked at the commencement of the study, is shown in Table 19 • 
Comparison of the nebulizer output with that of Yan et al (170) (0.003ml 
+ /- 0.0007ml) showed no significant difference (t-test p > 0 . 0 5 , Mann-
Whitney 2 tail probability 0.2438). Therefore, the Yan dosing schedule was 
assumed for the study. 
7.4 Computer generated random selection 
Probabilistic stratified sampling was used to minimise the sample variance. 
The five strata are defined above. The strata sizes are 317{Ni), 105(N2), 
170(N3)' 268(N4), and 627 ( � 5) . Sample size planning was done. A 
conservative size of about 180 was required, assuming the population 
prevalence of BHR to be 10-20% (15 + /- 5%). In order to get a reasonable 
number of BHR cases, it was decided that the sampling fractions for the 
strata with RSSA within the past year, should be about 1/5, whilst the 
sampling fractions without RSSA within the past year, should be about 1/10. 
The planned sizes for the 5 strata were therefore N^ 64, N2 11, N3 17, N4 
27, N5 63. Random numbers were generated by a computer soft ware called: 
EPISTAT. 
Of the 182 students selected for continuation in the study, 159 attended 
(870/0). Of the 23 non attendees 7 had left the CUHK, and 14 failed to attend 
after 3 appointments and one telephone call. Of the 159 who attended, 157 
underwent further questionning, bronchial challenge and skin tests. One 
student failed to perform lung function tests satisfactorily and one student 
refused to participate. Nonattendees and the two afore mentioned students 
were not included in the final statistical analysis. 
The final strata sizes of the 1 57 students undergoing challenge procedures 
were N^ = 6 0 , � 2 = 13, N3 = 13, N4 = 21 and Ng^BO. Seventy-one were male 
and 86 female. Of these 80% were indigenous to Hong Kong, the remainder 
were born in China. The age range of those studied was 18-28 years, mean 
18.9years. 
7.5 Recording of 'yes' when unsure of answers 
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Of the students who were interviewed (N = 159) a small number had 
recorded 'yes' because they were unsure of an answer. The percentage of 
respondants who recorded 'yes' because they were unsure is shown in Table 
20. Answers were corrected for statistical analysis. Regrouping of 2 
students occurred as a result of changed answers. 
7.权 Univariate statistical analysis 
7.61 BHR 
Twenty four students (24/157) displayed BHR. Of those 15 did not have a 
previous diagnosis of asthma, but all had or had had at least one RSSA ever. 
BHR was recorded equally amongst males and females.The range of severity 
of BHR was 0.1 jjmol to S.Ojjmol histamine. Figure 5 shows the distribution 
of BHR within the study population. When the grading of BHR was adopted 
(slight to severe) no students had severe BHR, 21% had moderate BHR, 
46% had mild BHR and 33% had slight BHR. 
7.62 Atopy 
〇f the students tested 100 (64%) had one or more positive response to an 
allergen 2mm greater than or equal to the saline control. In fact, 55% of all 
students had two or more positive responses, 50% three or more, and 41% 
of the tested population were considered to be highly atopic with four or 
more positive skin test reactions. Of those highly atopic individuals 62% 
were symptomatic. The number of students showing positive responses to 
the individual allergens {2mm greater than or equal to the saline control) is 
shown in Table 21. Sensitivity to house dust, D.pteronyssinus and D. farinae 
were most common. Furthermore, all students who displayed one or more 
response, as defined above, were sensitive to house dust. Of the students 
displaying a positive response, 61 % had a wheal size of 4mm or greater. 
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7.63 BHR and atopy 
In a univariate analysis of BHR all atopic indices are significantly associated 
with BHR (Table 22) The most significant association is found between the 
atopic index recording three or more positive skin test responses that are at 
least 2mm greater than the saline control. Positive responses (2mm > saline 
control) to the individual allergens D. farinae, D.pteronyssinus, house dust, 
cat and dog are also significantly associated with BHR 
(P = 0.001,0.001 6,0.001,0.0001,and 0.0149 respectively, Y^). There is no 
association between sensitivity to pollen, aspergillus and egg, and the 
presence of BHR ( P = 0.621, 0.06 and 0.621 respectively, 
Three students with BHR did not have atopy (12.5%). The PD20FEV1 values 
of these students were 1.1,2.9 and 0.1 ymoles respectively. They did not 
have a doctors diagnosis of asthma. Seventy-nine per cent of students with 
BHR (19/24) had four or more responses 2mm greater than or equal to the 
saline control. A reported history of eczema/rhinitis (with or without RSSA) 
is significantly associated with BHR (P = 0.023, "X^). 
7.64 Diagnosis of asthma 
The prevalence of asthma diagnosed by a doctor is 7.6% for the study group 
(12/157), and 4.8% of all students questioned (78/1,610). Of the 12 
diagnosed asthmatics in the study group 9 had had RSSA within the past 
year, 2 had not had RSSA within the past year but still had signs of atopy 
and 1 had been asymptomatic for over one year.Table 23 shows the range in 
prevalence rate of asthma for a range of diagnostic criteria for Hong Kong 
students. All those with a diagnosis of asthma had one or more positive skin 
test 2mm greater than or equal to the saline control. Three or more 
responses were recorded by 92% of the diagnosed asthmatics. 
7.65 BHR & doctors diagnosis of asthma 
A doctors diagnosis of asthma is highly significant to predict the presence of 
BHR (P = 0.000' X2). However, notably three of the nine doctor diagnosed 
asthmatics in the study group who reported RSSA within the past year, 
failed to show increased BHR when challenged with histamine. The three 
remaining doctor diagnosed asthmatics who did not report RSSA within the 
past year did display BHR. 
7.66 RSSA, doctors diagnosis of asthma and BHR 
There is a highly significant association between RSSA occurlng within the 
past year and BHR (P = 0.000, Further, a significant association exists 々 
between symptoms occuring within the past month and the actual PD20FEV1 
value (P = 0.015, Mann-Whitney). The severity of BHR, when grouped and 
graded as slight - severe, is also significantly associated with symptoms 
occuring within the past month (P = 0.000, Mann-Whitney). Past RSSA, in 
the absence of current ones, are non significant (P = 0.469, X^). RSSA 
occuring within the past year are associated with a diagnosis of asthma 
(P = 0.006, X^)-
7.67 Air quality and passive smoking 
Students who lived or had lived in Kwai Chung or Kwung Tong and been 
exposed to 'poor air quality' had a greater incidence of BHR and eczema or 
rhinitis, compared with students fron Shatin and the Southern district. 
(P = 0.04 and 0.03 r e s p e c t i v e l y , D<2) Exposure to passive smoking ever was 
associated with RSSA occurring within the past month {P = 0.001, "X?) no 
association was found between passive smoking and BHR. 
7.68 Place of birth 
Table 24 shows the incidence of BHR, diagnosed asthma, RSSA within the 
past year'and atopy for students born in Hong and students born in China. 
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8.Discussion 
The rapid method for measuring bronchial reactivity to histamine has been 
shown to accurately determine the prevalence and severity of BHR in large 
populations of subjects (21,37,46). We also found this to be the case. No 
serious side effects were observed apart from occasional mild hoarseness 
which resolved within minutes and one student felt slightly faint after 
completion of the skin tests, which was reported to the doctor but no 
medical intervention was necessary. The response rates at the 3 points in 
the study were good with 97% of students responding to QI, 82% to Qll 
and 86.5% undergoing challenge proceedures. The questionnaires showed 
good repeatability. “ 
We assumed a small proportion of students would be unsure of their 
answers when completing the questionnaires. To use interviewer controlled 
questionnaires would have reduced this problem but the resources were not 
available to conduct such a large undertaking and other biases would have 
been introduced by the interviewers. For this reason we asked those who 
were uncertain about any question to record "yes" to the answer. Following 
interview of those attending for challenge testing we could predict the 
margin of error of responses. The highest rate of those who recorded "yes" 
because they were unsure were 2.5% of those interviewed for the questions 
pertaining to lifetime exercise wheeze, a dry cough within the past 12 
months, and eczema within the past 12 months. Less than 2% of students 
were unsure of the answers for the remaining questions. No one was unsure 
of the questions asking if a doctor had diagnosed asthma in the past or if 
they were currently taking medications for asthma. 
The problem of interpreting questions that could lead to uncertainty of 
response (particularly in the detection of asthma) may be overcome by use 
Go 
of the video questionnaire. Recently used in New Zealand (198) to identify 
asthma, the video questionnaire was shown to be both valid and reliable. 
The authors concluded that the video questionnaire provides data that is 
"relatively free from biases due to language, culture, literacy or interviewing 
techniques". We suspect that some misinterpretation of the Chinese 
translation of the term "exercise wheeze", may have led to the extremely 
high prevalence of this symptom, as a sole symptom, in the females in our 
study. 
The criteria by which asthma is defined makes intercomparison of rates in 
different populations difficult. The well documented differences between 
asthma prevalence in different age groups (Figure 2) makes intercomparison 
with studies of different age groups from our own, difficult. Even looking at 
studies using the same criteria to identify asthma - a doctors diagnosis 
accurate comparison is still hard because of the different criteria each doctor 
will use to identify asthma. In our study the prevalence of asthma (as 
diagnosed by a doctor) was 4.8% (or 7.6% of the group selected for 
provocation testing). In the Australian study (40) of 20 year old students 
11 % had had a previous diagnosis of asthma by a doctor. In the Southern 
China study (37) the prevalence rate of asthma as diagnosed by a doctor 
was 2.1% in the 16-17 year old. Thus rates of diagnosed asthma in Hong 
kong are over twice those recorded in Southern China and almost half those 
recorded in Australia. This would fit in with the general trend observed and 
discusssed earlier (section 2.12) that asthma is most prevalent in Australasia 
and least prevalent in less developed countries. 
Whilst providing a relatively comparable diagnostic criteria, Salome (21) 
suggested that a doctors diagnosis of asthma may not give an accurate 
indication of asthma prevalence, because in their study 4.9 % of their 
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children had BHR and respiratory symptoms, but no diagnosis of asthma. We 
also found a number of students (54% of those with BHR, or 8.3% of the 
population tested) who had respiratory symptoms within the past year and 
demonstrated BHR, but had not had a doctors diagnosis of asthma. We did 
however find a highly significant association between BHR and a doctors 
diagnosis of asthma. Table 24 gives an indication of the different prevalence 
rates of asthma we found depending upon the defining criteria and highlights 
the problems of intercomparison of prevalence rates. 
The belief that BHR is an almost universal finding in current symptomatic 
asthmatics (4) has recently and consistently been challenged, in several 
asthmatic patients in Joseph's study (5) exacerbations of asthma occurred in 
the absence of BHR. More recently in a study of New Zealand schoolchildren 
(49) as many as 42% of children with a diagnosis of asthma and current 
respiratory symptoms did not have BHR. In Trigg's general population study 
(42) three of the 11 subjects with current asthma did not have BHR. Three 
of our nine students with a diagnosis of asthma and RSSA within the past 
year did not display BHR when challenged with histamine, so the association 
between BHR and diagnosed asthma is probably not complete. The exact 
reasons for the absence of BHR in the presence of current asthma are not 
known. The presence of BHR may be subject to a number of influences over 
a period of time, such as URTI, allergen exposure and avoidance-seasonal 
asthma, smoking, drug treatment and other factors as discussed. It would be 
very difficult to control for all of these variables, although we did control for 
URTI. So It seems reasonable to suggest that a single measurement at one 
time may not be an entirely satisfactory means of detecting this variable 
phenomenon. Pattemore (49) states further that identifying BHR by 
histamine or methacholine challenges is "a one dimensional assessment of a 
multi dimensional problem". Further attempts to explain normal BHR with 
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current asthma focuses on the continuous distribution of responsiveness 
giving no clear cut off between 'normal responsiveness' and 
'hyperresponsiveness' (199). Or on the premise that methods of measuring 
change in airway calibre, such as FEV], may not be a sensitive enough 
method of detecting these changes (5). 
When comparing those asthmatics with BHR and those without BHR no 
meaningful difference could be found between the mean atopic index sum 
(62) of the two groups (19.0 asthmatics with BHR versus 19.3 asthmatics 
without BHR). However, the asthmatics with BHR had an average of 2 skin 
test responses more than the asthmatics without BHR. The latter findings 
would imply that the asthmatics with BHR were more atopic than those 
without, but because the atopic sums for both groups were comparable 
more detailed investigations of atopic status are necessary. 
We measured the severity of BHR in two ways, individual PD20FEV1 values 
and grouped as slight to severe. BHR severity however defined was 
associated with RSSA occurring within the past month. The severity of 
RSSA, using severity score 2 (section 6. Expression and analysis of data) 
was significantly associated with the severity of PD20FEV1 when grouped as 
slight to severe , but not for individual PD20FEV1 values. Thus how BHR 
severity is defined will affect whether relationships exist. Others have found 
an association between BHR and symptom severity (21). Whilst Pattermore 
observed a trend for more children to have BHR and have a lower mean PD〗。 
with increased frequency of wheeze, he failed to show an association 
between BHR and wheeze within the past month (49). Others have failed to 
show an association between symptom severity and BHR (13). 
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In this study no individual displayed severe BHR, 21% had moderate BHR, 
46% mild and 33% slight BHR. In the Southern China study only one 
individual had severe BHR. The severity of BHR seems to be generally lower 
in our Hong Kong study and the Southern China study, than in others 
(21,42). The children in the New Zealand study (49) were of a comparable 
age to those in the China study, and our own students with those in 
Australia (40) which may indicate that where BHR does occur in this area of 
Asia, it is of a less severe nature. 
BHR may persist in asymptomatic asthmatic subjects for years (200). We 
found that BHR was present in all our asymptomatic asthmatics, implying 
that some residual airways inflammation exists (201). Further testing would 
be necessary to determine whether this inflammation is persistent or 
transient. Cockcfoft (63) showed that a number of asymptomatic asthmatics 
reactivity to histamine was normal with 69% of these demonstrating BHR 
only at times of exposure to relevant allergens. Little is known about 
spontaneous changes of BHR over longer periods of time. 
Frequently in population studies a proportion of asymptomatic nonasthmatic 
subjects have BHR (21,41,49,202}. We had no 'normal' Individuals who 
displayed BHR. Low prevalence rates of BHR among those without asthma 
symptoms in our age group have been documented, (203) which may help 
explain this finding. Three factors may contribute further - UTRI, (20) 
smoking (48) and abnormal lung function (42, 204), all have been shown to 
increase reactivity in non-asthmatics. We did not test subjects who had had 
a recent URTI : we had a very low number of students who were current 
smokers (N=4) ; and all subjects tested displayed normal lung function. 
Whilst considerable evidence exists to suggest that URTI will alter bronchial 
responsiveness (11, 20,148,149) some have failed to show this effect (19). 
Similarly, the effects of smoking are not conclusive with some demonstrating 
an age-dependent association with BHR (95), with younger smokers failing 
to show enhanced bronchial reactivity. We can only speculate that these 
three factors may account for the absence of normal individuals with BHR in 
our study. 
A very low proportion of students currently reported taking medications for 
asthma 0.4% (6/1610) of the total population. In keeping with the higher 
prevalence of asthma in males, more males than females reported taking 
asthma medications ever or within the past year. None of those who 
attended for provocation testing had used asthma medications within the ” 
past month, and only two students with symptoms and asthma reported 
using medications within the past year. This very low usage of asthma 
medications given the prevalence of doctors diagnosed asthma (4.8%), 
wheeze in the past year (12.5%), and BHR (15.3%) is hard to explain. The 
severity of BHR has been found to closely correlate with the amount of 
treatment required to control symptoms (63,205). The finding from our 
study of minimal drug therapy required to control symptoms and the absence 
of any 'severe' BHR may be linked. We can state that drug treatment will not 
have modified levels of activity, and thus not affected the results of 
challenge procedures. 
The prevalence of respiratory symptoms In our study is high, 45% of 
students reporting any respiratory symptom at some time in their lives, 
compared to 34% of children in Australia (21) and 30% in USA (31). Our 
questionnlare was based on that of Salome. The prevalence of wheeze ever 
was 15%, lower than the 24.3% (21) and 24% (40) reported in Australian 
schoolchildren and students, respectively. It is interesting that despite the 
age differences, both Australian studies reported the same prevalence rates 
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for wheeze. In Salome's study (21) 9% of children reported that nocturnal 
cough was their sole respiratory symptom and they therefore suggested that 
it was a useful additional question. However we found that no student 
reported this symptom as their sole symptom. Again in their study only 1 % 
of students reported exercise wheeze as their only symptom, which contrast 
with 12% in our study - which accounts for our high prevalence of 
respiratory symptoms ever. As discussed, it is not clear whether this 
represents a true prevalence of this symptom because of the problem 
interpreting the question. 
We found that a significant association exists between RSSA within the past 
year and BHR. This is in keeping with other studies (21) but contary to 
some. (42) We did not show any association between the symptom wheeze 
and BHR, contrary to others (37,42,46). However episodes of wheeze do 
occur in subjects without demonstrable BHR (21). Pattermore (49) et al 
found around 42% of those with current wheeze had normal bronchial 
responsiveness, this is comparable with our own finding that 39% of those 
with current wheeze had normal responsiveness. He found further that of 
those with wheeze within the past month 28% had normal responsiveness, 
we found 40% with normal responsiveness. However it is worth noting that 
we only had 5/157 students who reported wheeze within the past month. 
An increased prevalence of asthma in boys has been reported (206). We 
found this also to be the case, of those with asthma 60% were male. Peat et 
al (43) found a increased prevalence of BHR in boys but suggest that a 
stronger association occurs between sex and asthma than does between sex 
and BHR. They hypothesise further that girls have some protection not only 
against BHR but further protection against RSSA. Like Weiss (41) we failed 
to find any association between sex and BHR. Furthermore whilst the 
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symptoms (lifetime) wheeze, shortness of breath, tight chest, and nocturnal 
dry cough were evenly recorded by both sexes, exercise wheeze and waking 
from sleep with nocturnal wheeze, shortness of breath or cough were more 
prevalent in females. Thus this study suggests that girls are not protected 
from the development of BHR, and lifetime RSSA are more common in 
females (57%) than males (43%). We would agree that a stronger 
association occurs between asthma and sex than BHR and sex. 
The prevalence of atopy was high, with 64% of students displaying a 
positive response to one or more allergen (2mm greater than or equal to the 
saline control). This may be explained by our biased case sampling. As with 
BHR and asthma, comparison of atopy rates with other populations are 
difficult given the different defining criteria, nature of antigens used and the 
tendency of atopy to decrease with age (66). In a similar age group 
Cockcroft found the prevalence of atopy to be 34.8%《one or more 
responses 1-2 mm larger than the saline control) (45). In Australian students 
the prevalence of atopy was 58% when defined as one or more responses 
3mm greater than or equal to the saline control (40). Adopting their atopic 
definition, our atopy prevalence would be 55%. In Trigg's general 
population study (42) the prevalence of atopy was 39% (one or more 
response 1mm greater than saline control). If we adopt the same definition 
of atopy as the Australian students (a response of 3mm greater than or equal 
to the saline control) we can compare the rates of sensitivity to individual 
allergens. Similar rates of sensitivity to house dust and house dust mite were 
observed.Pollen sensitivity was considerably higher in Australian students 
than Hong Kong students (45% versus 1.9%). Although a wider range of 
pollens were used in the Australian study, we believe that this represents a 
real difference because Hong Kong is predominantly an urban society, where 
exposure to these allergens is expected to be much less. 
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Evidence suggests that the way atopy is defined may determine whether 
associations with BHR exist or not (54). In this study atopy was defined in a 
number of ways, using the number of responses, the sum of the size of the 
responses and a previously used adopted atopic index (62). However 
defined, atopy and BHR were associated, although the significance of 
association varied with the atopic definition. As (207) with the study in 
Southampton this association was significant independent of symptoms. 
This is in keeping with others (19,40,42,45,46,63>, but contary to some 
(54,65,208). When using the atopic definition of number of responses 
greater than or equal to the saline control, the greater the number of 
responses the more significant the association with BHR. These data suggest 
that an atopic status may be an important factor in the aetiology of 
nonspecific BHR. 
In Zhong's study (37) 13.6% of subjects with BHR had negative skin test 
responses. This is comparable to our own study where 12.5% (3 students) 
did not display atopy. In our study the airways of these students without 
atopy were quite reactive to histamine. We found that 5% of nonatopic 
students had BHR, which is less than the 10% found by Peat et al In 
Australian schoolchildren (62). These data would suggest that although a 
clear association does exist, the relationship is not complete. 
The finding of extremely high skin sensitivity to house dust and house dust 
mites in atopic individuals is in keeping with other studies from Hong Kong 
(57,68), where 100% of their atopic subjects were sensitive to house dust 
mites. Hong Kong's climate encourages mite proliferation - the bedding 
stored undisturbed during the long summer months in warm, humid 
conditions provides an ideal breeding ground for the mites, so when used, 
(o% 
individuals exposed to high levels of dust and dust mite occurs. Our study 
confirms that sensitivty to house dust and house dust mite in atopic 
individuals is higher in Hong Kong than elsewhere as discussed 
(69,70,71,72). 
We did not find a higher prevalence of BHR in students born to parents with 
asthma as others have (81). This would support the belief that genetics are 
not the major factor determining the presence of BHR (4,43). Furthermore 
only 13% of students with a doctors diagnosis of asthma report a parental 
history of asthma, compared with 50% previously documented (43,80), 
which does not lend support to belief that asthma is a directly inherited trait. 
However, of those with a parental history of asthma 72% reported RSSA or 
atopy or both, which would suggest that there is some genetic influence, but 
the extent of that influence remains uncertain. The results from our study 
indicate that factors other than a genetic disposition will influence the 
development of BHR and asthma. 
As in Woolcock's study of Australian schoolchildren (209), Smith et al (210) 
found that the prevalence of asthma in indigenous populations differed from 
the prevalence of those who had migrated there later in life. We found that 
the prevalence of diagnosed asthma was considerably greater in those born 
in Hong Kong than those born in China《9.6% versus 0%). It is difficult to 
determine whether this represents a real difference In asthma prevalence or 
is due to different diagnostic criteria or the presumed better health care 
available In Hong Kong. BHR was higher in Hong Kong-born students 
n6 .8%) than China-born students (9.4%). This would point to a real 
difference in asthma prevalence. However, there was no difference between 
Hong Kong-born or Chinese-born students for RSSA within the past year 
(380/0 versus 40%). Atopy (as defined by one or more positive response 
_ _ _ _ _ (cP) 
t 
2mm greter than or equal to the saline control) was slightly more common in 
Hong Kong born (65.6%) than China born students (56.3%), and the 
number of students recording three or more responses was higher in Hong 
Kong (53.6%) than China born students (37.5%). 
Restrictions were placed upon industry in Sha tin, New Territories (see 
Section 3) to prevent high levels of air pollution in a district anticipated to 
attract heavy industry. The result of the leglislation is that relatively low 
levels of air pollution exist in Sha tin (personal communication EPD, Hong 
Kong Government). Another district with low levels of air pollution is the 
'South side' of Hong Kong Island which is almost entirely residential. 
Combined these two 'good air quality' areas contain adequate numbers of 
students who have resided there for statistical analysis. Kwun Tong and 
Kwai Chung are areas with high levels of industry, dense population and high 
levels of air pollution. These areas were considered to have so called 'poor 
air quality' and were analysed against the 'good air quality' areas. In Kwun 
Tong annual levels of 71ugS02 ^ ^ have been recorded with residents being 
exposed to maximum daily concentrations almost four times that on 
occasions (211). The annual mean level in Kwun Tong is considerably higher 
than levels recorded in Sydney, where annual levels of 30ugS02 rn^ were 
recorded. Similarly, mean annual levels of total suspended particulates (TSP) 
in Kwun Tong at 120ug m^ were higher than the USA National primary air 
quality standards for TSP, 75ug m^ (personal communication EPD, Hong 
Kong Government). 
Those living in Kwai Chung and Kwun Tong (exposed to poor air quality), 
had an increased incidence of signs of atopy《eczema/rhinitis) and prevalence 
of BHR, compared to those in Shatin and the Southern district. Common air 
pollutants in the laboratory setting have been associated with increased BHR 
70 
(135,141,147) and increased asthma has been reported in association with 
high sulphate levels (138). Frequently in epidemiological studies a single 
symptom - nocturnal cough, occurs with a greater frequency in Urban areas 
with high levels of air pollution (209,212), we did not find any such 
association.We can only speculate that BHR and signs of atopy are linked 
with poor air quality, as we did not record internal air quality or measure 
socioeconomic status. 
We were unable to comment on the relationship between active smoking and 
BHR/asthma as only four students claim to have smoked or be current 
smokers and this was not a great enough number for meaningful statistical 
analysis. Passive smoking is difficult to quantify and the way it is quantified 
may dictate whether associations exist . Little published data exists on 
passive smoking in University students, most focuses on preschool to 
adolescent children or on the wives of smoking husbands. Koo et al (213) 
have described elaborate ways of quantifying passive smoke inhalation 
involving 1.5 to 2 hour interviews, Including questions on type of tobacco 
and total numbers of cigarettes smoked. From their work we identified 
questions we felt would give accurate information without the need for 
parental consultation. We asked if students were/had been exposed daily to 
cigarette smoke in the home and the number of years and mean hours per 
day that they had been exposed to that cigarette smoke. No association 
could be found between passive smoking, or years or hours of passive 
smoke exposure, and BHR or RSSA over the past year. However, when we 
looked at RSSA within the past month and passive smoking a significant 
association was found to exist, although there was no meaningful difference 
between the years or hours of smoke exposure between those with RSSA in 
the past month and those without. It is possible that some students may be 
more susceptible to the effects of passive smoking than others. However, 
72 
we were unable to observe any increased frequency of parental asthma 
history in those with RSSA past month and passive smoke exposure. Factors 
other than definition may affect whether an association exists or not, and 
may make comparison with other studies invalid. The effects of passive 
smoking may be age dependent (109,113) - in which case one would expect 
those who had been exposed to passive smoke for 18 years or so to show 
increased BHR or respiratory symptoms or decreased lung function. The 
effect of age upon passive smoking is not a consistent finding (121,122). 
Cessation of exposure to passive smoke has been shown to bring about 
clinical improvement a minimum of six months later (119), so arguably as 
many of the students had left home upon commencement of University term 
some effects of passive smoking may have been negated. Opinion is divided 
as to whether passive smoking will cause an increase in prevalence of 
asthma and RSSA as discussed. Maternal smoking appears to be a more 
important determinant of a positive correlation between passive smoking and 
asthma and RSSA (109). In our study almost exclusively smoking was only 
reported by fathers, grandfathers or uncles. 
Seasonal worsening of symptoms was reported most during the winter 
months. Figure 3 shows that in Hong Kong during the winter temperatures, 
humidity and rainfall are at their lowest. In addition to the cold dry air, 
bedding stored during the summer months will come into usage, complete 
with house dust and mites. Furthermore, typhoons and monsoons cease 
during winter leading to the possible accumulation of air pollutants-which 
during other times of the year may be dispersed by the strong winds. It has 
been documented that meteorlogical factors such as wind and rain will 
reduce the concentration of airborn particles (128). 
U 
f 
9. Conclusions and Recommendations 
This is the first study in Hong Kong to examine the relationships between 
BHR, asthma, RRSA and atopy. 
This study has demonstrated that associations do exist between BHR, doctor 
diagnosed asthma, RSSA within the past year and atopy as defined by skin 
prick testing. However, the associations were not complete, so no cause and 
effect can be implied. 
Not all diagnosed, symptomatic asthmatics displayed BHR, demonstrating 
that BHR is not a universal finding in asthma, when a single measurement is 
used to detect BHR. Some students with BHR failed to show atopy, and BHR 
was not related to RSSA within the past month. 
This study shows that no single measurement (ie, questionnaire data of 
RSSA; diagnosis of asthma; or BHR) can indepedently and accurately identify 
asthma in the community. 
The findings from this study would imply that some bronchial abnormality 
persists In asthmatics who have remained symptom free for a year or more. 
When screening for RSSA in subjects for whom English is not the first 
language the self-administered written questionnaire may not be entirely 
accurate. The main problem arising from the use of the self-administered 
questionnaire in this study was the understanding of the term "exercise 
wheeze" in Chinese. 
1 3 
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It is recommended that further studies be undertaken with greater man-
power, on larger numbers of subjects, in a more representative sample of the 
population, to establish accurate prevalence rates of BHR and atopy. Larger 
numbers of subjects would also enable more valid analysis of the effects of 
migration and genetic factors upon the prevalence of diagnosed asthma, 
atopy, BHR and RSSA. 
Longitudinal studies are necessary to determine if BHR is a variable 
phenomenon. It was not possible to conclude from a single BHR 
measurement if the absence of BHR in the diagnosed asthmatics was 
transient. 
Studies using the video questionnaire, to determine symptom prevalence, in 
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Table 1:- Prevalence of BHR and asthma 
Study/Year- A ^ B H R (definition) Asthma(definition) 
Canada 1984 20-29 10.3% 9.5% L/T 
(45) ^ 8 m g / m l histamine diagnosis +/or RSSA 
3% current 
within past month 
Australia 1986 15-30 35% 11 o/o L/T 
(40) <15^moles methacholine diagnosis 
Australia 1987 8-1 1 17.9% 12.8% L/T 
( 2 ” ^ 7.8^moles histamine diagnosis 
S. China 1990 11-17 4.1% 2.4% UT 
(37) ^ 7.8|jmoles histamine diagnosis 
New Zealand 7 - 1 0 15.9% 14.3% L/T 
1990 (49) 冬 7.S^jmoles histamine diagnosis 
UK 1987 18-64 14% 
(19) 18-24 14% 
35-44 10% 
55-64 24% 
冬 S^moles histamine 
UK 1990 18-75 23% 4.9%L/T 





* s t u d y p u b l i s h e d ~ “ “ 
L/T = l i fe t ime/cumulat ive prevalence 
diagnosis = asthma had been diagnosed by a medical pract ic ioner 
Table 2 Allergic diseases in a Chinese population of 6,563 (52) 
Disease Prevalence (%) 
Urticaria 20.6 
Drug Allergy 7.9 
Bronchial Asthma 5.3 
Allergic eczema 5.2 
Allergic rhinitis 3.4 
Food allergy 3.4 
Contact dermatitis 1.9 
Physical allergy 1.6 
Insect allergy 1.4 
Angioedema I .3 
Allergic laryngitis 0.3 
Pollen allergy 0.3 
Allergic purpura 0.2 
Allergic conjunctivitis 0.1 
Serum sickness 0.02 
Others 4 7 
9 0 










All causes of hay fever, } pollen 
grasses, trees, ragweed } 
Ingested allergens 
Milk, nuts, eggs, soya beans 
Aspirin, colouring substances 
Injected allergens 
Penicillin ] 
Bee venom } bronchospasm occurs 




Table 4:- Prevalence of allergen sensitivity in subjects attending PFL at PWH 
during 1989 (N = 265) 
Allergen % with sensitivity(reaction o f 》 2 m m ) 
D.pteronyssinus 58 
D.farinae 58 
House dust 54 
Cat fur 51 
Dog hair i 6 
Pollen 7.6 
Aspergillus fumigatus 5.3 
C|2 
Table 5:- Geographical d istr ibut ion of the general populat ion aged 15-24 (196) and f i rst year 
Chinese Universi ty of Hong Kong s tuden tsd 97) 
DISTRICT ^ “ 5UHK 
N= 1,012,859 N= 1.659 
N (%) TOTAL N (%) TOTAL 
HONG KONG 
Central & Western 3 8 , 8 1 5 (3.8) 61 (3.7) 
Wanchai 2 7 , 5 0 3 (2.7) 205 (12 .4 ) 
Eastern 8 1 , 4 4 5 (8.0) 45(2 .7 ) 
Southern 4 9 , 9 8 0 (4.9) 39(2 .4 ) 
1 9 7 , 7 4 3 (19.5) 3 5 0 ( 2 1 . 1 ) 
KOWLOON 
Kow loon City 7 6 , 3 7 7 (7.5) 202 (12 .2 ) 
K w u n Tong 148 .491 (14.6) 197(11 .9 ) 
Mong Kok 3 3 , 0 5 4 (3.3) 70(4 .2) 
Sham Shiu Po 7 8 , 5 8 9 (7.7) 133(8 .0) 
W o n g Tai Sin 1 0 2 . 0 2 5 (7.7) 127(7 :7) 
Yau Ma Tei 2 3 , 2 6 1 (2.3) 49(3 .0} 
4 6 1 , 7 9 7 (45.6) 7 7 8 ( 4 6 . 9 ) 
NEW TERRITORIES 
Islands 8 , 3 3 0 (0.8) 4《0 2) 
Nor th 2 7 , 0 4 1 (2.7) 21(1 .3) 
Sai Kung 8 , 0 6 4 (0.8) 7(0.4) 
Sha Tin 5 8 , 5 4 8 (5.8) 136(8 2) 
Tai Po 2 2 . 1 6 9 (2.2) 24(1 .4) 
Tseun W a n 5 0 , 2 4 6 (5.0) 97(5 .8) 
Teun M u n 3 4 , 0 7 6 (3.4) 3 4 (2.0) 
Yeun Long 4 2 , 4 1 3 (4.2) 40(2 .4} 
Kwa i Chung & 
T s i n g Y i 9 3 , 6 8 1 ( 9 . 2 ) 160(9 .6) 
3 4 4 , 5 6 8 (34.0) 5 2 3 ( 3 1 . 4 ) 
MISC 
Marine Area 8 , 7 5 1 (0.9) . 
Macau n/a 8 (o.5) 
s t X T , " " ' ' POP'Oenerd population aged 15-24; CUHK = Chinese University of Hong Kong, first year full time undergraduate 
93 
Table 6:- Advantages of i) closed questions and ii) self administered 
questionnaire. 
i) Closed questions 
greater precision 
uniformity 
easier coding and tabulation 
ii) Self administered questionnaire 
greater standardisation in the presented material 
elimination of interviewer bias 
reduced cost through savings in time and effort in administering the 
questionnaire 
easier questioning large numbers of individuals 
more leisurely, and possibly more careful, responding allowed 
q f A 丨 
Table 7:- Technical factors influencing response to challenge aerosols 
Aerosol generation 
nebulizer output 
aerosol particle size 
particle generation 
(intermittent versus continuous) 
reproducibility 
plumbing between generator and subjects mouth 
Aerosol inhalation 
particle size 
initial lung volume 
inspiratory f low rate 
mean residence time 
nose versus mouth breathing 
spontaneous versus controlled breathing 
airway calibre 
Table 8:- Guidlines for identifying a significant change in lung function 







FRC 25 (increase from baseline) 
Table 9:- Preconditions for bronchial provocation testing 
1. Lung function 
FEVi and FVC ^ 60% of predicted 
FEVi/FVC > 60% 
2. Medication 
No oral bronchodilators for 24 hours prior to testing 
No inhaled bronchodilators 6 hour prior to testing 
No antihistamines 48 hours prior to testing 
3. Symptoms 
No exacerbation of asthma for 4 weeks prior to testing 
No signs of breathiessness at rest 
4. Upper respiratory tract infections 
No cold for 4 weeks prior to testing 
98 
Table 10:- Chart of histamine doses (22) “ 
CHALLENGE A CHALLENGE B 
(abnormal subjects) (normal subjects) 
Dose No Cumulat ive Histamine No of Histamine j ^ o f 
dose (jumoles) concentrat ion inhalations concentrat ion inhalat ion 
I I 
1 0.03 fO.3% 1 [ I 
2 0.06 l0.3% 11 \0.e% Y 
I ~ ‘ ^ 
3 0.12 [0.6% y — 
4 0.24 [6.6% 21 |Q.6% ^ T -
5 0.49 |2：6% 21z 
6 0.98 |2.5% 2l [ Z ^ 少 3.丨 
7 1.80 b .5% 
8 3.91 |5.Q% "4| |5.0% 6 
9 7.8 日.0% ‘ 8 l |5.0% 8l 
Stop chal lenge when FEV^ falls by more than 2 0 % 
* If change in FEV^ > 1 0 % and < 2 0 % go to challenge A 
If change in FEV^ < 1 0 % cont inue w i th challenge B. 
9 8 
Table 1 1 A l l e r g i c responses produced by skin testing 
Type of Develops Description Resolution 
allergy 
Immediate minutes (max 10-15) urticarial weal 1-2 hours 
(I) (with erythema) 
Arthus several hours oedematous swelling 24-36 hours 
《III) (often extensive, 
usually soft) 
Delayed 24-48 hours firm induration several days 
《丨V) (surrounded by oedema 
of the skin tissues) 
qc 
Table 12:- Factors affecting the results of skin testing 
Location of site 
Adequate distance between sites 
Correct controls - both positive and negative 
Time of reading response 
Use of medication by subject 
Selection of allergens for testing 
Storage of allergens 
Potentcy of allergens 
Correct instrument technique 
100 
1 
Table 13:- Measures of repeatability of a)QI and b)QII administered six weeks 
apart. 
a) Ql: Lifetime symptoms 
Question kappa proportion average correct 
in agreement classification rate 
1. Wheeze ^ O ^ 
2. Exercise wheeze 0.74 0.90 0.96 
3. SOB/tight chest 0.72 0.88 0.95 
4. Nocturnal dry cough 0.58 0.84 0.94 
5. Woken from sleep 
with SOB/wheeze/cough 0.67 0.92 0.94 
6. Diagnosis of asthma 1.0 "1.0 0.99 
7. Medications (ever) 1.0 1.0 0.99 
8. Medications (current) 1.0 1.0 1.00 
9. Childhood respiratory 
disease 0.85 0.94 0.97 
10. Eczema 0.65 0.96 0.93 
11. Rhinitis 0.81 0.90 0.95 
12. Parental asthma 0.65 0.98 0.98 
b) Qll: Symptoms within the past year 
1. Wheeze — 0 . 8 7 8 
2. Exercise wheeze 0.912 0.98 0.98 
3. SOB/tight chest 0.768 0.88 0.97 
4. Nocturnal dry cough 0.624 0.94 0.97 
5. Eczema 0.788 0.94 0.93 
6. Rhinitis 0.833 0.92 0.93 
IQI 
Table 14:- Prevalence of lifetime symptoms in CUHK students 
Symptom N (1,610) % 
1. Wheeze 246 15.3 
2.Exercise wheeze 491 30.5 
3. SOB/Tight chest 231 14.4 
4. Nocturnal dry cough 213 13.2 
5. Nocturnal wheeze/SOB/cough 182 11.3 
6. Diagnosis of asthma 78 4.8 
7. Medications ever for asthma 85 5.3 
8. Current medications for asthma 6 0.4 
3. Childhood chest trouble 112 7.0 
10. Eczema 295 18.3 
11.Rhinitis 391 24.3 
12.Parental asthma 61 3.8 
1 0 2 
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Table 15:- Prevalence of lifetime symptoms (Ql) according to sex in CUHK 
students 
Symptom Sex Total 
male female 
N % N % 
1 .Wheeze 116 47.2 130 52.8 246 
2.Ex wheeze 195 39.5 296 60.3 491 
3.S0B/t ight 
chest 107 46.3 124 53.7 231 
4.Nocturnal 
dry cough 104 48.8 109 51.2 213 “ 
5.Nocturnal 
wheeze/SOB/ 78 42.9 104 57.1 182 
cough 
6.Diagnosis 47 60.3 31 39.7 78 
7. Medications 
ever 52 61.2 33 38.8 85 
8. Medications 
current 4 66.7 2 33.3 6 
9.Childhood 
reps, illness 69 61.6 43 38.4 ” 2 
10.Eczema 155 52.5 140 47.5 295 
11.Rhinitis 207 52.9 184 47.1 391 
12.Parental 
asthma 35 57.4 26 42.6 61 
N = number ; SOB = shortness of breath “ — 
(05 . 
Table 16:- Prevalence of symptoms within the past year (Qll) of CUHK 
Students 
Symptom N % 
(593) 
1.Wheeze 74 12.5 
2.Exercise wheeze 200 33.7 
3.S0B/Tight chest 101 17 
4.Dry nocturnal cough 110 18.5 
5.Eczema 125 21.1 
6.Rhinitis 212 35.8 
N = number ; SOB = signs of breathlessness 
4 
Table 17:- Prevalence of symptoms within the past year (Qll) according to sex 
in CUHK students 
Symptom ^ “ 
male female 
N % N % 
1.Wheeze 37 50 37 50 74 
2. Exercise 
wheeze 76 38 124 62 200 
3.SOB/ 
tight chest 50 49.5 51 50.5 101 
4.Dry nocturnal 
cough 51 46.4 59 53.6 n o 
5.Eczema 64 51.2 61 48.8 125 
6.Rhinitis 104 49.1 108 50.9 212 
N = number ;SOB = signs of breathlessness “ “ ~ ~ 
1 0 5 ^ 
Table 18:- Nature of symptoms 
A. Time of last symptom 
Symptom Symptom last occurred, 
(months ago) 
1 1 - 6 6 - 1 2 
N % N % N % 
1.Wheeze 30 5.1 26 4.4 18 3 
2. Exercise 125 21 58 9.8 17 2.9 
wheeze 
3.S0B/t ight 34 5.7 45 7.6 22 3.7 
chest “ 
B. Frequency of symptom 
Symptom Number of times symptom occurred 
(past year) 
> 1 2 4-12 < 4 
^ % N % ti % 
1 .Wheeze 6 1 16 2.7 52 8.8 
2.S0B/t ight 6 1 17 2.9 78 13 
chest 
Results expressed as % of total responders to Qll 
N = number ; SOB = signs of breathiessness 
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Table 19:- Mean nebulizer output per squeeze measured on two separate days 
Nebulizer number Mean output (ml) - one discharge 
Day 1 Day 2 
1 0.0027 0.0023 
2 0.0033 0.0029 
3 0.0025 0.0027 
4 0.0022 0.0024 
5 0.0028 0.0027 
6 0.0024 0.0023 
7 0.0027 0.0026 … 
8 0.0026 0.0028 
9 0.0024 0.0023 
10 0.0024 0.0025 
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Table 20:- Percentage of students who recorded 'yes' because they were 
unsure of answers. 
Question Number Ql (%)* Ql(%)# Qll(%)* Q||(%)# 
1 0.6 0.06 1.3 0.12 
2 2.5 0.25 1.9 0.19 
3 1.3 0.12 0.6 0.06 
4 1.9 0.19 2.5 0.25 
5 0.6 0.06 2.5 0.25 
6 0 0 1.9 0.19 
7 0.6 0.06 
8 0 0 
9 0.6 0.06 ’ 
10 1.3 0.12 
11 0.6 0.06 
12 0.6 0.06 
Q l * , Q l l * expressed as a percentage of 159 
QI#,QII# expressed as a percentage of total populat ion, 1 ,610 . 
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Table 21:- Number of students and sensitivity individual allergens 
N ‘ A l l e r g e n V ^ 
House dust 87 55 100 
House dust mite 82 52 95 
D. farinae 80 51 92 
Cat 65 41 75 
Dog 37 24 43 
Egg 10 6.4 11.5 
Pollen 10 6.4 11.5 
N = number ;%1 expressed as a % of total students N = 157; %2 expressed as a % of atopic 
s tudents ^ 
(oy 
Table 22:- Significance of association of atopic indices with BHR 
Index Association(P) 
Index 1 • The number of positive responses to allergens 2mm > saline control 
response 2mm ：^ saline control 0.012 
> 2 responses 2mm》sa l i ne control 0 .0012 
responses 2mm 务 saline control 0 .0008 
Index 2. The number of positive responses to allergens ^ histamine control 
> 1 response ^ 2 m m and ^ histamine control 0.0095 
responses 务2mm and 乡histamine control 0 .0030 
》3 responses > 2 m m and ^ histamine control 0.0031 
Index 3. (62) 0 .0026 〜 
Index 4. Sum of all responses》a l ine control 0 .0014 
I I P 
Table 23:- Prevalence rates of asthma in CUHK students using a number of 
definitions 
Definition of asthma Prevalence 
rate 
BHR and wheeze past month 1 g% 
BHR and doctors diagnosis of asthma and RSSA past year 3 .8% 
BHR and wheeze past year 5.1% 
BHR and doctors diagnosis of asthma 5.7% 
BHR and any RSSA past month 6.4% 
Doctors diagnosis of asthma 4.8-7 .6%* 
Wheeze past year 8 3% 
BHR and RSSA past year 1 2 1 % 
BHR and RSSA ever 15 30/。 
* 12/157 from study group, 78/1610 from questionnaire data alone 
l l \ 
Table 24:- BHR, diagnosed asthma, RSSA-past year and atopy in Hong 
Kong-born and China-born students 
Parameter Hong Kong % China-born ^ 
-born 
酬 21/125 16.8 3/32 9.4 
Diagnosed asthma 12/125 9.6 0/32 0 
RSSA-past year 47/125 37.6 13/32 40.6 
Atopy 1* 82/125 65.6 18/32 56.3 
Atopy 67/125 53.6 12/32 37.5 
A t o p y ” - one or more responses 2 m m greater than or equal to saline control 
A t o p y 3 * = t h r e e or more responses 2 m m greater than or equal to saline control 
1 1 2 
Figures 
Figure 1 Study design 
Figure 2 Asthma prevalence and age in USA 
Figure 3 Monthly mean temperature, mean relative humidity and total rainfall 
for Hong Kong (July 1989 _ June 1990) 
Figure 4 Study plan highlighting final numbers of students 
Figure 5 Distribution of BHR within the population 
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Figure 1 S t u d y Design 
Questionnaire I (Ql) 
l i fe t ime h is tory of RSSA [ l i f e t ime history of a topy f [no past h istory “ 
+ a t o p y symptoms 
i 7 ^ 
Questionnaire II (Qli) / 
RSSA-past year atopy symptoms no history -pas t l / 
+ /- a topy - past year year / 
^"^^^^^^^^^Comj l^er Generated Random Selection 
\ 、等 、f s / V 
Histamine Inhalation Challenge 
Skin Prick Testing 
l/tA 
Figure 2:- Asthma * prevalence and age in USA 
% pop. 
With 丨5 一 h 
asthma / \ 
Age group 
Ac t ive asthma : "ever had asthma and ever seen a doctor , w i th one at tack in past year or if 
medical t rea tment has been received." 
Pop = populat ion 
Figure 3:- Monthly mean temperature, mean relative humidity and total rainfall 
for Hong Kong (July 1989-June 1990). 
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Figure 4:- Study plan highlighting final numbers of students 
Questionnaire KQI) N=1 .610 
Li fet ime history of RSSA jL i fet ime history of a t o p y f I n o past h istory 
+ /- a topy symptoms 
N = 715 N = 268 N = 627 
Questionnaire 2 (QID- ^ l is ionresponders N= 123} \ 
, _ _ _ \ • r \ 
RSSA-past yeat A topy symptoms No history - ‘ \ 
+ /- a topy -past year past year \ 
丨 _ _ ^ ^ v 
N = 317 N = 1 0 5 N = 1 7 0 IN = 268 N = 627 
. j N i ) (N,) (N3) (N,) 1 (N 口） 
^"^^"^"^^^^mputer generated r ^ d o m selecti^nonattendees N = 2 1 
y / ^ refusal/ fai lure N = 2 
N = 6 Q [ | N = 1 3 [ 1 N = 1 3 [ N ^ ， N = 5 ( r 
I 
Histamine Inhalation Challenge 
Skin Prick Testing 
i n 
Figure 5:- Distribution of BHR within the population 
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Appendix 1 Consent Form. 
ASTHMA STUDY 
PRINCE OF WALES HOSPITAL 
DEPT. MEDICINE, CUHK 
CONSENT FORM 
I have been informed that the Chinese University of Hong Kong is conducting a 
study on asthma. The purpose of the study is to determine the exact 
prevalence of asthma in the community and to examine the relationship of 
symptoms to allergy, responsiveness of the lungs, and the environment. 
丨 agree to take part in this study and understand that 丨 w i " undergo tests of 
lung function, skin prick tests for allergy and histamine inhalation tests. These 
proceedures have been explained to me. 
I understand that my participation is entirely voluntary and I may withdraw 
from the study at any time.丨 understand that the information collected about 
me will be kept confidential and that I w川 not be identified personally irf the 
reporting of the results. 
If I have further questions I may contact Christine Douglass on 0-6363031. 
Participants signature & date. Signature for s t u d y ~ 
& date 
NAME (PRINT) NAME (PRINT) 
CODE NUMBER 
1 copy for participant 
1 copy for study 
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A p p e n d Q . ① 二 
Please complete this questionnaire. It is part of a study to detect asthma in Hong Kong, 
a disease that often goes undetected. We very much appreciate your cooperation in this 
study which will not only increase our knowledge of asthma, but also provides you with 
tl^ e opportunity for a complete, free, respiratory check up by experts, if you have the 
disease. 
All information obtained in this study will be kept confidential and for medical research 
only. . 
If you have any questions regarding the questionnaire or would like further informa-
tion, please contact Christine Douglass, Department of Medicine, Prince of Wales 
Hospital, 0-6363031. 
Please answer the questions by drawing a drcle around the appropriate response. 
For example: Do you live in Hong Kong? ‘ 
C ® ) NO 
Some questions wi l l ask for additional information, please be as accurate as possible. If you 
are uncertain about, or require help with a question please record YES. 
NAME . 




HOME TELEPHONE NUMBER 
ADDRESS AT UNIVERSITY (if different) 
UNIVERSITY DEPARTMENT & FACULTY 
1 
please turn over 
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1. Have you ever wheezed? 1. YES NO 
‘ ‘(wheeze is a wliistling noise that comes from the chest) 
• ( wheeze = “喘吓”，是劇烈地喘息，並從胸内傳出呼「嚇嚇」嚇聲), 
2. Have you ever wheezed during or after exercise? 2. YES NO 
"• " ‘ .'• i • ‘ • . . . . • - • • - • , . • • . • •• - • • -, .. • . - • - . .. ‘. . .. . • • • • . . . . . . 
3. Have you ever had attacks of shortness of breath or a 3. YES NO 
tight chest? 
• . . _ _ . - -
4. Have you ever had a dry cough at night, not associated 4. YES NO 
with a chest infection (such as a cold or influenza)? 
5. Have you ever woken from sleep wi th shortness of 5. YES NO 
breath, wheezing or coughing? 
6. Have you ever been diagnosed as having asthma by a 6. YES NO 
doctor or at a hospital? 
If yes, at what age was the asthma diagnosed? years. 
7. Have you ever taken medications for asthma? 7. YES NO 
8. Are you currently taking any medications for asthma? 8. YES NO 
If yes, please list 
9. Did you have any chest trouble before the age of 16 years? 9. YES NO 
10. Have you ever had eczema? 10. YES NO 
(eczema is a dry, itchy rash, on the face, arms or legs) 
(eczema =濕疼，是臉上、手、或脚上的發癢乾斑） 
11. Have you ever had rhinitis? 11. YES NO 
(rhinitis is sneezing, runny or blocked nose, itchy eyes 
or nose, not associated with a cold) 
( rh in i t is = “鼻炎”’鼻炎的病徵楚在沒有患上感冒或傷風的情形下 
時常有噴噴、流鼻涕或鼻塞’鼻孔或眼睛痕癢，尤其是在早上） 
12. Have either of your natural parents ever had asthma? 12. YES NO 
PLEASIE RETURN TOGETHER W I T H THE UNIVERSITY HEALTH QUESTIONNAIRE 
、：、 A p p e n d U V c?. G ? I L 
、 - • t 
Thank you for completing the first questionnaire which has assisted us in our researc] 
into asthma in Hong Kong. ^ 
You have been selected to complete a second questionnaire. Please complete thi 
questionnaire and return it in the envelope provided as soon as possible. 
All information in this study will be kept confidential and used for medical researcl 
only. 
If you have any questions please contact Christine Douglass, Department of Medicine 
Prince of Wales Hospital, 0-6363031. 
Please answer the question by circling the appropriate response (yes/no), or ticking (V) th( 
appropriate box. If you are uncertain about, or require help with a question, please recorc 
YES. 
NAME 
DATE OF BIRTH 
(day / month / year) 
SEX Male/Female 
CONTACT TELEPHONE NUMBER. : 
1. Within the past 12 months have you wheezed? 1. YES NO 
(wheeze is a whistling noise that comes from the chest) 
(wheeze = “喘吓”’足劇烈地喘息，並從胸内®出呼「嚇嚇」嚇/�$ ) “ 
If yes,a) when did the last wheeze occur? 
one month ago 
1-6 months ago 
7-12 months ago 
b) how many wheezing attacks did you have? 
less than 4 over the paf>t 12 months 
4-12 over the past 12 months 
more than 12 over the past 12 months 







2. Within the past 12 months have you wheezed during 
or after exercise? 
2. YES NO 
If yes, when did the last wheeze associated with exercise 
occur? * 
one month ago 
1-6 months ago 
7-12 months ago 
3. Within the past 12 months have you had any attacks of 
shortness of breath or a tight chest? 
3. YES NO 
If yes, a) how many attacks? 
Less than 4 over the past 12 months ’ 
4-12 over the past 12 months 
more than 12 
b) when did the last attack occur? 
one month ago 
1-6 months ago 
7-12 months ago [ _ _ _ 
4. Within the past 12 months have you had a dry cough 
at night not associated with a cold or chest infection? 4. YES N〇 
5. Within the past 12 months have you had eczema? 
(eczema is a dry itchy rash on the face, arms or legs) 5. YES NO 
(eczema =：鹏,足臉上、f.、成卿上的發银乾斑） 
6. Within the past 12 months have you had rhinitis? 
(rhinitis is sneezing, runny or blocked nose, itchy eyes 
or nose, not associated with a cold) 6. YES NO 




A p p e n d i x 3 , A d d i t i o n a l q u e s t i o n s 
ASTHMA STUDY 
PRINCE OF WALES H O S P I T A L , DEPT. M E D I C I N E CUHK 
F I N A L QUEST IONNAIRE 
NAME - CODE 
DEPARTMENT „DATE&TIME： 
P l e a s e a n s w e r t h e f o l l o w i n g a d d i t i o n a l q u e s t i o n s 
1 . W h e r e w e r e y o u b o r n ? 
2 - H a v e y o u a l w a y s l i v e d i n H o n g K o n g YES NO 
I f y e s , w h i c h d i s t r i c t & how many y e a r s , i f n o , w h i c h 
c o u n t r i e s a n d how many yea；广sT^ainswe广 o n a t t a c h e d s h e e t -
3 . H a v e y o u e v e r s m o k e d ? YES NO 
4 - Do y o u c u r r e n t l y s m o k e ? YES NO 
I f y e s , h o w m a n y / d a y „ „ , - . w h e n w a s y o u r l a s t c i g a r e t t e . „ . . 
5 - H a s a n y m e m b e r o f y o u r h o u s e h o l d s m o k e d c i g a r e t t e s o r 
p i p e s i n y o u r p r e s e n c e i n t h e home? YES NO 
I f y e s , f o r how many y e a r s h a v e t h e y s m o k e d i n y o u r p r e s e n c e ? 
. . . . „ y e a r s . 
A p p r o x i m a t e l y how many h o u r s p e r d a y w e r e y o u e x p o s e d t o t h e 
s m o k e ? … … - h o u r s 
6 « D o y o u o r h a v e y o u ever h a d p e t a n i m a l s i n t h e home? 
YES NO 
I f y e s ， p l e a s e l i s t 
7«HAVE YOU TAKEN ANY DRUGS FOR ASTHMA W I T H I N THE PAST 2 4 
HOURS? YES NO 
( c h e c k no i n h a l e d b r o n c h o d i l a t o r s f o r 6 h o u r s p r i o r t o 
t e s t i n g 
no o r a l b r o n c h o d i l a t o r s f o r 2 4 h o u r s p r i o r t o t e s t i n g 
no a i n t i h i s t a i m i n e s 4 8 h o u r s p r i o r t o t e s s t i n g ) 
8.WHEN WAS YOUR LAST ATTACK OF ASTHMA 
( c h e c k no a t t a c k w i t h i n p a s t 6™8 w e e k s ) 
9 « H a v e y o u h a d a c o l d w i t h i n t h e p a s t 4 w e e k s ? 
YES NO 
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H O N G K O N G I S L A N D 
A- C E N T R A L & W E S T E R N 
B , E A S T E R N 
C . S O U T H E R N 
D„ W A N C H A I 
K O W L O O N 
E- K O W L O O N C I T Y 
F\ K W U N T O N G 
G- M O N G K O K 
H- S H A M S H U I PO 
J- W O N G T A I SIN 
K . Y A U M A T E I 
N E W T E R R I T O R I E S 
L I S L A N D S 
M . N O R T H 
N . S A I K U N G -
.P. S H A T I N 
Q . T A I PO 
R- T S E U N W A N 
S . T U E N M U N 
L Y U E N L O N G 
U„ TvSING 丫I & K W A I C H U N G 
Y„ M A C C A U 
W C H I N A 
X E L S E W H E R E 
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A p p e n d i x S t u d y c h a r t s 
A S T H M A S T U D Y 
P R I N C E O F W A L E S H O S P I T A L’D E P T - M E D I C I N E , C U H K 
H I S T A M I N E C H A L L E N G E T E S T R E S U L T S 
N A M E - D E P A R T M E N T . 
S E X C O D E ： … … D A T E ‘ T I M E … … … -
H i s t a m i n e c h a l l e n g e t e s t p e r f o r m e d A / 8 
P r e c o n d i t i o n 
1 . F E V 1 / F V C > 6 0 % 
2- E x c l u d e if F E V 1 < 6 0 % 
— y 
Concentration N o . of F E V recorded 1 m i n . FEV % PEF 
inhalation aiter inhalation fall change 
^^^^^^^^^^^^^^mmmmma^^^mrnrnmimimm w^^^mmmmmimmm^^^^^m^mmm^^mm^^mmmm^^m^m^^mmmmm^^^^^mammmm^ ^^mmmm^^mmmm^mrnmm^a^^^^ •^^^^mmmmhhhm^MM mmmm^mmmmmmaamm^mmm^mmamrnM 
Pre 
NS 1 
1 ^ ” 








% . ^ ^ 
8 
Post 3 min. ‘ 
P o s t 5 m i n . 
Post 7 min. 
Post 9 min. 
P o s t B . D . 
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